Back to the drug test guide

Sources for the Drug Test Guide

  1. A Kratom Metabolite Causes False Positive Urine Drug Screening Results for Methadone (conference abstract) 2020 Describes discordant CEDIA EDDP results in urine containing kratom alkaloids. The investigators compared the metabolite screen, parent methadone assay and mass spectrometry.
  2. ELISA Screens for Fentanyl in Urine Are Susceptible to False-Positives in High Concentration Methamphetamine Samples J Anal Toxicol, 2022 A forensic laboratory found that urine with more than 40 micrograms/mL methamphetamine could trigger the Neogen fentanyl ELISA at its 1 ng/mL decision point.
  3. Spectrofluorimetric Determination of 7-Aminoclonazepam, a Major Clonazepam Metabolite, in Human Urine: A Factorial Design of Experiment Approach to Optimize Method Development Luminescence, 2024 A dedicated spectrofluorimetric study identified the genuine clonazepam metabolite 7-aminoclonazepam in patients’ urine after dosing. It does not evaluate sensitivity of routine benzodiazepine immunoassays.
  4. ACMT Position Statement. Interpretation of Urine for Tetrahydrocannabinol Metabolites 2020 Explains what a confirmed THC metabolite in urine can establish and why a THC-containing product can account for a genuine positive.
  5. Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations J Anal Toxicol, 2005 Urine from children given ketamine for anesthesia contained ketamine and norketamine by mass spectrometry. The study establishes a medical source of both analytes.
  6. A Case of Esmolol-Induced False-Positive Amphetamine Urine Drug Test Cureus, 2021 This case describes delayed cardioversion after a patient receiving esmolol had an unexpected stimulant screen. It adds a clinical example to the separate experimental evidence for esmolol.
  7. Immunalysis tapentadol assay reformulation resolves tramadol interference J Anal Toxicol, 2025 Twenty-eight specimens with unconfirmed tapentadol positives on the original Immunalysis 343 kit were negative when retested with the reformulated 343UR kit. Tramadol was present below the older insert's stated interference threshold in 61%.
  8. ADLM Guidance Document on Laboratory Testing for Drugs of Misuse to Support the Emergency Department 2026 Separates a presumptive immunoassay result from definitive identification and explains how test menus and cross-reactivity affect emergency department interpretation.
  9. Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies Am J Case Rep, 2021 A child's cannabinoid screen was positive after delta-8 THC gummies and specialized testing identified delta-8 THC in urine and serum. It is related-cannabinoid detection.
  10. Specificity of the EMIT drug abuse urine assay methods Clin Toxicol, 1981 The archived 1981 primary paper reports historical EMIT urine challenges, including explicit confirmation of glutethimide on the barbiturate screen. Its broad counts and references to insert claims do not identify every positive drug–assay pair in the large cross-tabulation.
  11. Investigation and Resolution of Interference in the LC-QTOF-MS Detection of 4-MePPP J Anal Toxicol, 2021 The confirmed error involved a tramadol metabolite fragment generating an LC-QTOF library match for 4-MePPP. It applies to that mass-spectrometry workflow. It does not establish immunoassay cross-reactivity.
  12. Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine Clin Toxicol (Phila), 2006 The venlafaxine metabolite O-desmethylvenlafaxine interfered with identification of tramadol in one historical LC–MS/MS urine method.
  13. TAC topical anesthesia produces positive urine tests for cocaine Ann Emerg Med, 1990 After simple lacerations were treated with the cocaine-containing TAC local anesthetic, 14 of 18 next-morning urines screened positive for benzoylecgonine and 15 were positive by GC-MS.
  14. American Bio Medica Corporation. Rapid TOX urine drug screen product instructions, revision C 2009 The manufacturer lists benzocaine and hydroxyzine among compounds its urine panel did not detect below 100,000 ng/mL. It lists no exception for either drug on the TCA, cocaine or benzodiazepine strips. The TCA strip uses a 1,000 ng/mL nortriptyline cutoff.
  15. A screening method for urinary methamphetamine--latex agglutination inhibition reaction test Forensic Sci Int, 1985 A prototype latex methamphetamine urine test reacted with ephedrine derivatives, phentermine and methoxyphenamine. Glucose and albumin effects discussed separately do not establish medication causation.
  16. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant direct ELISA presumptive assays for amphetamine and methamphetamine J Anal Toxicol, 2007 The Bio-Quant antibody comparison measured relative response to stimulants in standards. The study separately assessed the effect of urine as a matrix. Standard reactivity is kept distinct from a post-dose positive urine.
  17. ARK Ketamine II Assay. Export package insert, revision 4 2026 Quetiapine tested negative on ARK Ketamine II at both ketamine cutoffs in the manufacturer's study. The insert also gives individual results for other tested medicines.
  18. ARK Pregabalin II Assay. Performance data sheet, revision 01 2019 The ARK data sheet records no gabapentin cross-reaction at 5,000 µg/mL on its pregabalin assay.
  19. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening Clin Chem, 1995 The large CEDIA/EMIT/RIA evaluation explicitly identified sympathomimetics among unconfirmed amphetamine specimens. The original results distinguish compounds identified by GC-MS from isolated challenges.
  20. False-positive ethyl glucuronide immunoassay screening associated with chloral hydrate medication as confirmed by LC-MS/MS and self-medication Forensic Sci Int, 2009 A patient case and chloral hydrate self-administration produced EtG immunoassay signals without measurable EtG or EtS by LC-MS/MS. The patient had a result above the stated cutoff.
  21. False-positive ethyl glucuronide immunoassay screening caused by a propyl alcohol-based hand sanitizer Forensic Sci Int, 2012 After intensive use of a sanitizer containing both propanol isomers, seven volunteers’ experiments showed DRI EtG interference. LC-MS/MS found propyl glucuronides without EtG, and spiking reproduced the response to 1-propyl glucuronide.
  22. Inhalation but not transdermal resorption of hand sanitizer ethanol causes positive ethyl glucuronide findings in urine Forensic Sci Int, 2014 Mass spectrometry measured genuine EtG after repeated use of ethanol hand sanitizer and after vapor-only exposure. Local exhaust substantially reduced the urine signal.
  23. Cross-reaction of propyl and butyl alcohol glucuronides with an ethyl glucuronide enzyme immunoassay Forensic Sci Int, 2014 Adding alcohol glucuronides to EtG-free urine showed that 2-propyl glucuronide strongly cross-reacted with the DRI EtG assay. Methyl, 1-propyl, 1-butyl and 2-butyl glucuronides reacted more weakly. Tert-butyl glucuronide showed almost no reaction.
  24. Excessive urinary excretion of isopropyl glucuronide after isopropanol abuse Forensic Sci Int, 2016 An individual with a history of using industrial cleaning fluid had a strong DRI EtG signal. LC-MS/MS found abundant isopropyl glucuronide and no EtG.
  25. Lessons learned from a case of tert-butyl glucuronide excretion in urine - "New" psychoactive alcohols knocking on the back door? Forensic Sci Int, 2017 Two samples from a patient with solvent exposure screened positive on DRI EtG but contained no EtG on LC-MS/MS. Several other alcohol glucuronides were measured, including tert-butyl glucuronide.
  26. Ayala-Lopez and colleagues. Point-of-care urine drug screening study, version 1 data and analysis code 2020 On the Alere point-of-care cocaine screen, documented benzocaine exposure preceded 429 negatives, four unconfirmed positives and eight confirmed positives. Hydroxyzine exposure preceded 164 negatives, one unconfirmed positive and one confirmed positive.
  27. A Computational Approach to Identify Interfering Medications on Urine Drug Screening Assays without Data from Confirmatory Testing J Anal Toxicol, 2021 Urine spiking verified interference from carbidopa and levodopa on the local enzymatic acetaminophen assay below 40 micrograms/mL. Entacapone required 400 micrograms/mL, and methyldopa and its alpha-methyldopamine metabolite also interfered.
  28. Analysis of Electronic Health Records Reveals Medication-Related Interference on Point-of-Care Urine Drug Screening Assays J Anal Toxicol, 2022 A hospital's EHR and point-of-care spiking study found labetalol could trigger MDMA, and ranitidine could trigger methamphetamine, opiates and propoxyphene; the latter two required substantially higher concentrations.
  29. Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine J Anal Toxicol, 2005 DRI Oxycodone was negative in authentic oxycodone-negative urines containing high concentrations of codeine, hydrocodone, hydromorphone or morphine. The authors provide separate concentration lower bounds for each drug.
  30. Ofloxacin causes false-positive immunoassay results for urine opiates Addict Biol, 2000 A clinical case report describes an unexpected urine opiates screen following ofloxacin during drug-treatment monitoring.
  31. Benzathine interference in the EMIT-st urine amphetamine assay Clin Chem, 1987 The authors identified benzathine interference on the EMIT-st urine amphetamine test. This points to the salt component when interpreting reports involving benzathine penicillin.
  32. Quinolones and false-positive urine screening for opiates by immunoassay technology JAMA, 2001 Thirteen quinolones were compared on five opiate assays. Nine crossed the positive threshold on at least one, and volunteers receiving levofloxacin or ofloxacin supplied positive urine samples.
  33. ortho/meta/para-Methylacetylfentanyl-Induced Unique Interferences in Fentanyl Urine Drug Testing with Immunoassay and LC-MS/MS J Appl Lab Med, 2025 A proficiency specimen containing three methylacetylfentanyl isomers tested positive on ARK Fentanyl II. Separate challenges showed different reactivities, and all three shared key ion transitions with fentanyl in the laboratory's LC-MS/MS method.
  34. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine Forensic Sci Int, 2014 A mixture of buprenorphine and norbuprenorphine affected an Immunalysis K2 Spice screen at the investigators’ lower cutoff. It stayed below the recommended cutoff.
  35. Validation of an ELISA Synthetic Cannabinoids Urine Assay Ther Drug Monit, 2015 NMS urine synthetic-cannabinoid ELISA Table 2 names 93 comparator substances. None triggered the screen at 1,000 µg/L or appreciably suppressed the cutoff control. The same assay recognized some related synthetic cannabinoids.
  36. The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results J Anal Toxicol, 2011 Reference standards and patient urine tied trazodone’s metabolite mCPP to positive Roche Amphetamines II results. GC-MS excluded amphetamine, methamphetamine and MDMA in the tested patient samples.
  37. Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications Ment Health Clin, 2024 A patient taking oral naltrexone repeatedly screened positive for oxycodone. Confirmation detected noroxymorphone, a minor metabolite that helps explain the screen.
  38. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse Drug Test Anal, 2014 The original urine challenge tables report measured signals and reagent cutoffs on CEDIA amphetamines/ecstasy, buprenorphine, benzodiazepines, PCP and cocaine reagents. The separate authentic case table gives counts; coexposure cannot identify a cause by itself.
  39. False-positive urine screen test for MDMA in a patient exposed to mebeverine Br J Clin Pharmacol, 2021 This individual clinical report documents a possible mebeverine–MDMA screening association. A later, separate study supplies the controlled-administration and metabolite evidence in the checker.
  40. Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids Subst Abuse Rehabil, 2015 A volunteer gave a false-positive CEDIA buprenorphine specimen after taking prescribed-dose codeine with acetaminophen. Among 2,272 clinical specimens, 25 screens failed confirmation and many contained codeine, morphine or their metabolites.
  41. Cross-reactivities and structure-reactivity relationships of six benzodiazepines to EMIT(®) immunoassay J Pharm Biomed Anal, 2013 Six benzodiazepines or metabolites were tested in fortified urine. Emit II Plus recognized pinazepam, delorazepam and brotizolam more strongly than the tested flunitrazepam, nitrazepam and midazolam metabolites.
  42. [Immunologic studies of benzodiazepine--the effect of structural characteristics on cross-reactivity] Arch Pharm (Weinheim), 1991 Antibody testing placed diazepam alongside the nordiazepam reference on the historical TDx urine benzodiazepine method. The remaining medications were less reactive, but the abstract does not assign them individual thresholds.
  43. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride J Anal Toxicol, 2013 Two amisulpride-treated patients had CEDIA buprenorphine results that failed LC-MS/MS confirmation. The authors also measured low cross-reactivity for amisulpride and sulpiride.
  44. Does Labetalol Trigger False Positive Drug Testing Results? J Addict Med, 2023 When investigators added parent labetalol to four specimen types, amphetamine and methamphetamine immunoassay positives occurred in meconium. The urine tests stayed negative at the concentrations studied.
  45. Efavirenz treatment and false-positive results in benzodiazepine screening tests Clin Infect Dis, 2009 In a comparison of 100 people with HIV, 49 of 50 taking efavirenz had at least one positive benzodiazepine screen, compared with one of 50 without efavirenz. The investigators identified 8-hydroxyefavirenz as the interferent.
  46. Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine J Toxicol Clin Toxicol, 2003 A child with a large venlafaxine overdose had an Abbott AxSYM urine screen positive for PCP and negative confirmatory GC-MS. The investigators reproduced the signal with a mixture of venlafaxine and O-desmethylvenlafaxine.
  47. Hallucinations in a child: a case demonstrating the pitfalls of urine dipstick drug testing J Forensic Leg Med, 2008 A child taking an ephedrine cough mixture had a positive amphetamine urine dipstick. Gas chromatography found ephedrine and no amphetamines.
  48. [Urinary toxicological screening: analytical interference between niflumic acid and cannabis] Arch Pediatr, 2009 A child receiving niflumic acid suppositories screened positive for cannabinoids. Chromatography of the same specimen detected niflumic acid and found no cannabinoids.
  49. Comparison of methaqualone excretion patterns using Abuscreen ONLINE and EMIT II immunoassays and GC/MS Forensic Sci Int, 1996 After six adults received methaqualone, both Abuscreen ONLINE and EMIT II detected the exposure. Hydrolyzed urine testing implicated conjugated hydroxylated metabolites as major contributors to both screens.
  50. Mephenytoin overdose--phenytoin poisoning incognito? Case report and mephenytoin/phenytoin comparison J Toxicol Clin Toxicol, 2000 The authors flag potential barbiturate urine positivity with mephenytoin. Their abstract describes a mixed mephenytoin/valproate overdose but does not document that patient's barbiturate result, reagent or confirmatory testing. Retained as unresolved.
  51. A Cross-Reactivity of Fenofibric Acid With MDMA DRI Assay Mil Med, 2016 In a French military cohort, all 22 positive DRI ecstasy results among 15,169 urine specimens failed MDMA confirmation by GC-MS. The investigation identified interference associated with fenofibrate’s metabolite.
  52. Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment J Anal Toxicol, 2005 Patients prescribed dihydrocodeine had unconfirmed positive CEDIA buprenorphine results. The comparator assessed actual urine by GC-MS and ELISA at the reported 5 ng/mL CEDIA cutoff.
  53. Sevoflurane metabolite cross-react in the ethyl glucuronide DRI® immunoassay Drug Test Anal, 2018 This case correspondence reports that a sevoflurane metabolite interfered with the DRI EtG immunoassay.
  54. False-Positive Urine Drug Screen for Benzodiazepines in a Child Taking Fluoxetine Pediatr Emerg Care, 2021 The published case identifies a child taking fluoxetine with an unexpected urine benzodiazepine result.
  55. False-positive immunoassay results for urine benzodiazepine in patients receiving oxaprozin (Daypro) Clin Chem, 1995 This early Clinical Chemistry report identifies presumptive benzodiazepine positives during oxaprozin therapy. Fraser and Howell later described the earlier series as four patients and three volunteers.
  56. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methamphetamine in urine Clin Chem, 1987 Compared Abbott stimulant FPIA with Syva EMIT. Phenylpropanolamine and ephedrine had very limited Abbott antibody response. Threshold crossing is not documented in the abstract.
  57. Aripiprazole causing false positive urine amphetamine drug screen in an adult patient with bipolar disorder Compr Psychiatry, 2019 The authors followed amphetamine screen signals alongside aripiprazole dose and plasma concentration in an adult taking 15–30 mg daily.
  58. Evaluation of two enzyme immunoassays for the detection of the cocaine metabolite benzoylecgonine in 1,398 urine specimens J Clin Lab Anal, 2012 When added to urine at 10,000 ng/mL, bupivacaine, lidocaine, mepivacaine, ropivacaine and tetracaine did not trigger either the DRI or Lin-Zhi benzoylecgonine assay.
  59. Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay J Med Toxicol, 2011 Of 128 emergency department amphetamine screens that failed confirmation, 53 belonged to patients with a recorded bupropion prescription. The center screened with Syva EMIT II Plus and checked every positive by gas chromatography.
  60. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine J Anal Toxicol, 1996 The investigators’ LSD microplate assay showed approximately 0.0008% cross-reactivity with ergonovine, compared with substantially greater reactivity for nor-LSD.
  61. CEDIA Heroin Metabolite (6-AM) Assay, manufacturer instructions 10006723-10-EN, August 2017 2017 The later CEDIA heroin-metabolite instructions list negative challenge results for several opioids. These help interpret differences from an earlier CEDIA experiment.
  62. Characterization of an Amphetamine Interference from Gabapentin in an LC-HRMS Method 2020 During development of a urine LC–HRMS confirmation method, concentrated gabapentin produced a fragment that met the initial qualitative criteria for amphetamine. The investigators identified the fragment and modified the method to separate it.
  63. False-Positive Urine Ethyl Glucuronide Results in Pregnancy Caused by Escherichia coli Urinary Tract Infection O G Open, 2026 In one pregnancy complicated by recurrent E. coli urinary infection, urine EtG was repeatedly positive while urinary ethanol and ethyl sulfate and whole-blood phosphatidylethanol were negative. The authors attributed the pattern to postcollection bacterial synthesis.
  64. False positive urine drug screening for tricyclic antidepressants in patients taking quetiapine Aust N Z J Psychiatry, 2011 This publication reports positive urine TCA screens attributed to quetiapine in treated patients.
  65. Cross-reactivity of nefopam and its metabolites on three different urine benzodiazepines immunoassay screenings: A comparative study Toxicologie Analytique et Clinique, 2020 The index patient had a positive EMIT Atellica screen without benzodiazepines by chromatography. Direct parent-drug challenges were negative. Urine from two of three treated patients interfered on Architect, and CEDIA was negative throughout.
  66. Detection of methadone, LAAM, and their metabolites by methadone immunoassays J Anal Toxicol, 1999 Spiked drug-free urine showed that levomethadyl and methadol reacted on several methadone assays. Cross-reactivity varied markedly by platform and metabolite.
  67. Use of Lisdexamfetamine or Amphetamine? Interpretation of Chiral Amphetamine Analyses J Anal Toxicol, 2022 Chiral analysis found only d-amphetamine in urine and blood from 18 people receiving chronic lisdexamfetamine. The storage experiments found no conversion to l-amphetamine under the tested conditions.
  68. Localization of the epitope in methamphetamine and its antibody use for the detection of methamphetamine and benzphetamine by polarization fluoroimmunoassay J Immunoassay, 1995 The experimental dual-target urine assay directly recognized benzphetamine and methamphetamine. The parent-drug challenge is distinct from benzphetamine yielding genuine methamphetamine after ingestion.
  69. Abnormal Urine Drug Screens in Pregnancy- Opportunity for Laboratory Stewardship EJIFCC, 2025 The investigators explicitly treated postpartum positive fentanyl screens following labor epidural analgesia as expected in the post-intervention period. Clinical classification and limited confirmation preclude attributing unrelated screens to specific medicines.
  70. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens Forensic Sci Int, 2004 The One-Step buprenorphine ELISA reported negative challenges for 11 named compounds, including codeine, morphine, dihydrocodeine and pholcodine. It was validated across matrices, including human urine. Patient false positives were not ascribed to the negative challenges.
  71. Enzyme immunoassay validation for the detection of buprenorphine in urine J Anal Toxicol, 2003 Singlestep buprenorphine ELISA produced no reaction with ten named comparator drugs at 1 and 10 mg/L in urine. The study supports reagent-specific negatives alongside the different CEDIA findings.
  72. LSD screening in urine performed by CEDIA® LSD assay: positive interference with sertraline J Anal Toxicol, 2012 The publication reports sertraline interference with the CEDIA urine LSD assay.
  73. Detection of amphetamine and methamphetamine following administration of benzphetamine J Anal Toxicol, 1998 GC-MS detected d-amphetamine and d-methamphetamine in urine after controlled benzphetamine administration. The relative amounts differed between people.
  74. Amphetamine and fenproporex levels following multidose administration of fenproporex J Anal Toxicol, 1999 All five volunteers in a seven-day fenproporex dosing study excreted amphetamine. Both amphetamine enantiomers were found, and parent fenproporex was detectable in samples with higher amphetamine concentrations.
  75. Amphetamine enantiomer excretion profile following administration of Adderall J Anal Toxicol, 2003 After five adults received 20 mg of mixed amphetamine salts, GC-MS identified both d- and l-amphetamine in urine, with d-amphetamine predominating. This documents expected detection of the prescribed drug.
  76. Amphetamine excretion profile following multidose administration of mixed salt amphetamine preparation J Anal Toxicol, 2004 Five participants received 20 mg mixed amphetamine salts daily for five days. Urine contained genuine amphetamine; some GC-MS-positive specimens were missed because the immunoassay responded differently to enantiomers.
  77. Enantiomeric composition of amphetamine and methamphetamine derived from the precursor compound famprofazone Forensic Sci Int, 1996 After a volunteer took 50 mg of famprofazone, urine testing identified both the d and l forms of amphetamine and methamphetamine. This documents actual metabolic production of both analytes.
  78. Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines Clin Biochem, 2019 In spiked urine, levofloxacin triggered MULTIGENT opiates and CEDIA buprenorphine; moxifloxacin triggered MULTIGENT amphetamine/methamphetamine. Ciprofloxacin was negative across ten assays. Levofloxacin was also negative on the oxycodone and methadone methods tested.
  79. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage Pediatrics, 2015 A child with butyrfentanyl overdose had a positive fentanyl urine screen. This is evidence of recognition of a related analogue; it does not quantify the false-positive rate after exposure.
  80. Case report of a phencyclidine false positive due to lamotrigine use with confirmatory testing Am J Emerg Med, 2022 A patient taking lamotrigine had a positive urine PCP screen, detectable serum lamotrigine and a negative admission blood test for PCP.
  81. Cross-reactivity of tapentadol specimens with DRI methadone enzyme immunoassay J Anal Toxicol, 2012 Tapentadol and three metabolites reacted on the DRI parent-methadone assay. In 97 selected urine specimens, mass spectrometry confirmed tapentadol-related compounds and excluded methadone. The DRI EDDP assay did not react in the challenges.
  82. Lisdexamfetamine and amphetamine pharmacokinetics in oral fluid, plasma, and urine after controlled oral administration of lisdexamfetamine Biopharm Drug Dispos, 2021 LC-MS/MS measured real d-amphetamine and intact lisdexamfetamine in urine after six volunteers received lisdexamfetamine. This supports an expected amphetamine result from metabolism.
  83. Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times J Anal Toxicol, 1991 After controlled heroin administration, GC-MS identified urinary 6-acetylmorphine. The same study found no measurable 6-acetylmorphine after morphine or codeine administration.
  84. Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays J Anal Toxicol, 1992 Four opiate assays differed in recognition of genuine opiates. Coat-A-Count was selective for free morphine. Abbott TDx, Abuscreen and EMIT detected a wider range. Individual unlisted cutoffs cannot be inferred.
  85. Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays J Anal Toxicol, 1993 After heroin, morphine or codeine administration, four general opiate assays gave different responses when compared with GC-MS. The screens commonly detected codeine exposure, with substantial variation between samples.
  86. Evidence that morphine is metabolized to hydromorphone but not to oxymorphone J Anal Toxicol, 2008 LC-MS/MS found small amounts of hydromorphone in urine from patients receiving high-dose morphine alone. It found no oxymorphone after high-dose morphine or hydromorphone.
  87. Urine methamphetamine-to-amphetamine ratio by LC-MS/MS to differentiate methamphetamine use from pharmaceutical impurity in patients prescribed amphetamine J Mass Spectrom Adv Clin Lab, 2025 Two laboratories studied small methamphetamine signals in specimens from people prescribed amphetamine. Methamphetamine was also measurable in an Adderall XR product and a commercial amphetamine calibrator, supporting pharmaceutical impurity as one explanation.
  88. The effect of the use of mouthwash on ethylglucuronide concentrations in urine J Anal Toxicol, 2006 Two mouthwash exposure studies measured urine EtG after volunteers gargled with a product containing 12% ethanol. The intensive exposure produced higher values than the repeated, ordinary-use condition.
  89. Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay Clin Biochem, 2012 Adding certain baby washes to drug-free urine produced a THC screening signal. Testing of individual surfactants helped identify the source of interference.
  90. False-positive results from the Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy Clin Chem, 1993 In the clinical series, urine from patients taking chlorpromazine, fluspirilene or pipotiazine sometimes screened positive for amphetamine on monoclonal EMIT. Polyclonal testing and gas chromatography helped resolve the discrepancies.
  91. A field evaluation of five on-site drug-testing devices J Anal Toxicol, 2002 In the DUI field study, expanded confirmation commonly identified MDMA in amphetamine positives or hydrocodone/hydromorphone in opiate positives. This concerns true related-drug recognition and differences between panels.
  92. Immunoassay cross-reactivity of phenylephrine and methamphetamine Pharmacotherapy, 2012 A hospitalized patient initially screened negative for methamphetamine and later screened positive after intravenous phenylephrine. Follow-up evaluation implicated phenylephrine or its metabolites.
  93. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine J Anal Toxicol, 1992 Six amphetamine or methamphetamine assays responded differently to ephedrine and phenylpropanolamine isomers. At 100 mg/L all spiked samples were negative. At 1,000 mg/L some became positive, particularly on EMIT.
  94. Variability amongst urine toxicology amphetamine readings with concurrent administration of fenofibrate Australas Psychiatry, 2018 The authors discuss an amphetamine screening result during fenofibrate treatment in psychiatric care and the consequences of relying on a preliminary result.
  95. Rifampin interference with opiate immunoassays Clin Chem, 2002 In two patients tested before and after rifampin, post-dose urine screened positive for opiates on Syva RapidTest and Genix RapidTech but stayed negative on Biosite Triage and GC-MS. Adding rifampin to blank urine reproduced interference on Syva and Genix.
  96. [Etryptamine, a new designer drug with a fatal effect] Z Rechtsmed, 1986 The investigators of an etryptamine intoxication described a response on the EMIT-st amphetamine assay and described urine detection of the drug.
  97. Elimination of fluconazole interference in gas chromatography/mass spectrometric confirmation of benzoylecgonine, the major metabolite of cocaine using pentafluoropropionyl derivative J Forensic Sci, 1996 The researchers separated fluconazole from benzoylecgonine by changing the derivatization step for GC-MS. The previously described interference could obscure detection of the cocaine metabolite.
  98. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine Ther Drug Monit, 2007 Adding hydroxyzine or its metabolite cetirizine to serum produced an apparent tricyclic antidepressant signal on a fluorescence polarization immunoassay. Both also raised the measured concentration in serum that already contained a tricyclic.
  99. Cross-reactivity of stimulants found in sports drug testing by two fluorescence polarization immunoassays J Anal Toxicol, 1996 Volunteer dosing, chromatographic analysis and two Abbott amphetamine assays separated metabolic formation of amphetamine, recognition of related stimulants, and test-specific negative results in Tables II–V.
  100. Rifampicin causes false-positive immunoassay results for urine opiates Clin Chem Lab Med, 1998 Rifampicin cross-reacted in laboratory measurements on the Cobas-Integra KIMS opiate assay. Experiments indicated an effect beyond the color of the antibiotic solution.
  101. Development of a radioimmunoassay for the determination of buprenorphine in biological samples Analyst, 1993 The buprenorphine RIA recognized norbuprenorphine much more than the glucuronides. Its small response to etorphine was not shown to produce a positive test in a patient.
  102. Pseudoephedrine and false-positive immunoassay urine drug tests for amphetamine Pharmacotherapy, 2013 This published letter discusses pseudoephedrine and urinary amphetamine immunoassays. Underlying primary challenges carry greater evidentiary weight; the no-abstract citation alone adds no patient or test details.
  103. Development and Validation of a High Sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing (preprint with Supplemental Tables 1 and 2) 2025 Supplemental Table 1 in the authors’ preprint gives the individual standards reported as nonreactive on their investigational urine xylazine dipstick, including lidocaine. The table can be searched by source cell in the accompanying register.
  104. Biochip array technology for new psychoactive substances detection in biological samples: Evaluation of the specificity of the Randox Evidence Investigator® Ann Clin Biochem, 2022 The full paper separately reports the 40 urine specimens. Several medicines coincided with unconfirmed piperazine, clonazepam or etizolam results. Coexposures and author hypotheses are retained. Trazodone can produce real mCPP.
  105. False-positive fentanyl colorimetric urine screening caused by risperidone: a diagnostic pitfall Clin Chem Lab Med, 2026 This report adds a urine colorimetric fentanyl screening method to the literature associating risperidone with unexpected positive fentanyl results.
  106. Positive predictive values of abused drug immunoassays on the Beckman Synchron in a veteran population J Anal Toxicol, 2001 Beckman Synchron urine amphetamine screening was positive above 43 µg/mL ranitidine in this laboratory. The authors associated their unusually high false-positive burden with local ranitidine use.
  107. Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis Ther Drug Monit, 2016 A DRI hydrocodone/hydromorphone study tested other opioids at 5,000 ng/mL. Oxycodone and oxymorphone showed minimal response; the accessible summary does not state that either crossed the 100 ng/mL cutoff.
  108. DRI Methaqualone Assay. Instructions for use, 0762-9-EN 2021 A mecloqualone challenge at 500 ng/mL produced a positive DRI methaqualone screen. The compounds are related sedatives.
  109. Detection of benzodiazepines and tribenzazolams by TRIAGE: confirmation by solid-phase extraction utilizing SPEC.3ML.MP3 microcolumns and GC-MS J Anal Toxicol, 1994 Triage benzodiazepine testing was compared with EMIT and expanded GC-MS. An oxazepam-only confirmation can miss legitimate alprazolam and other benzodiazepine metabolites.
  110. Cross-reactivity of nefopam and its metabolites with benzodiazepine EMIT immunoassay J Anal Toxicol, 2008 This indexed laboratory report specifically addresses nefopam and its metabolites in a benzodiazepine EMIT immunoassay.
  111. A sensitive solid-phase fluoroimmunoassay for detection of opiates in urine Appl Biochem Biotechnol, 2000 The prototype morphine-based assay strongly recognized codeine, oxycodone and a morphine glucuronide, whereas methadone showed little binding. These are assay-development results, not frequencies among treated patients.
  112. Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology Drug Test Anal, 2014 In the Randox synthetic-cathinone validation, neither ephedrine nor pseudoephedrine produced a signal above the detection limit on the two antibody channels. The study also documented effects of strongly acidic urine.
  113. Investigative implications of the instability and metabolism of mebeverine J Anal Toxicol, 2006 The authors describe cross-reaction by mebeverine, its alcohol and related compounds. The fatal-case concentrations they measured were in blood, so those values cannot be taken as urinary positivity thresholds.
  114. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay J Anal Toxicol, 1990 Abbott TDx recognized the delta-8 isomer of the THC carboxy metabolite along with the delta-9 metabolite and its glucuronide.
  115. Express Diagnostics International. DrugCheck GHB Single Test. Instructions, DC260A-FU0 0812 2012 The DrugCheck insert warns that high urine ascorbic acid can interfere with its GHB strip and describes use of a second strip to check for vitamin C.
  116. False positive results for the CEDIA™ Mitragynine Immunoassay caused by methadone and EDDP in clinical specimens (meeting abstract B-279) 2025 Methadone and EDDP triggered the CEDIA mitragynine screen in fortified urine. Both compounds were also present in some specimens where the kratom screen failed confirmation.
  117. False-positive fentanyl urine screening during treatment with paliperidone: a case report 2026 A patient receiving paliperidone screened positive for fentanyl in urine. LC–MS/MS found neither fentanyl nor its metabolites.
  118. False-positive phencyclidine (PCP) on urine drug screen attributed to desvenlafaxine (Pristiq) use BMJ Case Rep, 2017 This case describes an unexpected Medtox PCP result while the patient was taking prescribed desvenlafaxine, the active metabolite of venlafaxine.
  119. FDA 510(k) decision summary for Quidel Triage TOX Drug Screen, K182719. Analytical specificity tables 2019 The submission identifies drugs detected on the Quidel Triage TOX channels and substances that react with its tricyclic antidepressant channel, including chlorprothixene. Benzocaine at 100 µg/mL did not alter the expected results in urine, including on the cocaine and TCA channels.
  120. FDA 510(k) decision summary. Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA, K190397 2019 Immunalysis reported a positive meprobamate screen at a felbamate challenge concentration of 120,000 ng/mL. The device targets the carisoprodol metabolite.
  121. FDA 510(k) K060896. Varian OnTrak TesTcup II and OnSite CupKit. Decision summary, methamphetamine at 300 ng/mL 2006 The Varian device study lists positive methamphetamine-channel challenges with compounds including propylhexedrine and phenylephrine at the stated concentrations.
  122. FDA 510(k) K142353. First Sign Drug of Abuse Dip Card Test and Cup Test. Interference and specificity studies 2014 First Sign documented a positive amphetamine challenge with apomorphine at 50,000 ng/mL and tested additional compounds on its dip card and cup devices.
  123. FDA 510(k) K142396. Chemtrue BUP/TCA drug screen dip card, cup and cassette tests 2014 The manufacturer found no interference from benzocaine at 100 µg/mL in the BUP/TCA device challenge around the screening cutoffs. The TCA test was calibrated against nortriptyline.
  124. FDA 510(k) K153693. Immunalysis Methamphetamine Urine Enzyme Immunoassay 2016 Phentermine added at 1,000,000 ng/mL was negative in the methamphetamine-specific urine assay.
  125. FDA 510(k) K221871. Healstone Accurate Drug of Abuse Urine Test Cup and Cup Rx. Specificity, AMP 500 and AMP 1000 channels 2022 Diethylstilbestrol triggered the Healstone AMP 500 and AMP 1000 channels at different challenge concentrations, 2,500 and 5,000 ng/mL respectively.
  126. FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test Dip Card 2025 The manufacturer tested substances in drug-free urine and in urine containing 50% below or above its assay cutoffs. Diphenhydramine, bupropion, cyproheptadine and prednisone were individually listed as noninterfering at 100 µg/mL; the submitted test menu includes tramadol, the TCA class and two methamphetamine cutoffs.
  127. FDA De Novo decision summary. LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay, DEN170010 2018 On the LZI meprobamate assay, 400 ng/mL of felbamate gave the response of 100 ng/mL meprobamate. The FDA summary also describes how the assay responds to carisoprodol.
  128. FDA decision summary K053035. Acro Rapid Benzoylecgonine (Cocaine) Urine Test 2006 Benzocaine at 100 µg/mL did not alter the expected results in urine containing 150 or 450 ng/mL of benzoylecgonine, on either side of this test’s 300 ng/mL cutoff.
  129. FDA decision summary K053422. RapidOne Cocaine 150 Test 2006 Procaine added to drug-free urine produced a positive result at 75,000 ng/mL on this 150-ng/mL benzoylecgonine strip.
  130. FDA decision summary K122961. Wondfo Methamphetamine Urine Test (MET 500) and Amphetamine Urine Test (AMP 300) 2013 Dextroamphetamine at 50,000 ng/mL generated a positive result on the methamphetamine-specific 500-ng/mL urine test. It is also the intended analyte on the separate amphetamine channel.
  131. FDA decision summary K152590. Coretests ACCU NEWS Drug Screening Test Card and Urine Cup 2016 The dedicated MET1000 urine channel did not reach the cutoff with 100,000 ng/mL of d-amphetamine. The same compound is the intended target of the distinct amphetamine channel.
  132. FDA decision summary K171695. First Sign Multi-Drug Dip Card and Cup Tests 2018 The applicant challenged the devices with 100 µg/mL of procaine and of prednisone in urine. Neither changed concentrations near the decision boundary into a different test result.
  133. FDA decision summary K213875. Microgenics DRI Tricyclics Serum Tox Assay, urine interference study 2022 At 5,000 ng/mL of added hydroxyzine, the urine control below the 300 ng/mL nortriptyline cutoff stayed negative and the control above it stayed positive. The assay was evaluated in urine despite its product name. In urine, chlorpromazine at 600 ng/mL reached the 300 ng/mL cutoff. Hydroxyzine at 5,000 ng/mL, carbamazepine at 5,000 ng/mL and carbamazepine epoxide at 30,000 ng/mL preserved the expected low and high urine control results.
  134. 13-year-old girl with recurrent, episodic, persistent vomiting: out of the pot and into the fire Pediatrics, 2015 A pediatric report attributed an unexpected cannabinoid screen to IV pantoprazole. This is a single, suspected drug association and does not establish reactivity of every PPI or cannabinoid device.
  135. Amphetamine positive urine toxicology screen secondary to atomoxetine Case Rep Psychiatry, 2013 An adult taking atomoxetine had a positive CEDIA amphetamine screen after a seizure. GC-MS found no amphetamines.
  136. False-positive phencyclidine immunoassay results caused by metronidazole Clin Toxicol (Phila), 2018 The authors reported PCP immunoassay interference associated with metronidazole.
  137. High concentrations of dextromethorphan result in false-positive in opiate immunoassay test Clin Chim Acta, 2015 This report describes a false-positive opiates immunoassay in the presence of high dextromethorphan concentrations.
  138. False-positive methadone drug screens during quetiapine treatment J Clin Psychiatry, 2010 A clinical series described methadone-positive urine screens in 10 inpatients taking quetiapine. The report includes patients who became positive after previously testing negative.
  139. Unexpected Fentanyl Detection during a Liver Transplant Evaluation Clin Chem, 2023 After an unconfirmed ARK Fentanyl II result during transplant evaluation, investigators compared clinical urine results with drug-free urine spikes. Ciprofloxacin above 40 µg/mL triggered a positive, as did desmethyl-ofloxacin at 5 µg/mL. Both concentrations occurred in patients’ urine.
  140. Improved CEDIA benzodiazepine assay eliminates sertraline crossreactivity J Anal Toxicol, 1997 Sertraline metabolites interfered with the original CEDIA benzodiazepine assay. In a comparison of 531 screens, a reformulated assay improved specificity and performed similarly to EMIT II.
  141. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine J Anal Toxicol, 1998 After 12 volunteers received a single dose of oxaprozin, all 36 specimens screened positive for benzodiazepines on EMIT and CEDIA, and 35 did so on Abbott FPIA. Oxaprozin standards also reacted.
  142. Lack of interference by nabilone in the EMIT d.a.u. cannabinoid assay, Abbott TDx cannabinoid assay, and a sensitive TLC assay for delta 9-THC-carboxylic acid J Anal Toxicol, 1989 The authors reported that nabilone did not interfere with the EMIT d.a.u. or Abbott TDx cannabinoid assays or with their thin-layer test for a THC metabolite.
  143. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values J Anal Toxicol, 1996 Five urine benzodiazepine assays were compared after dosing alprazolam or triazolam. Triage missed the serial specimens in this study, while assay thresholds and enzymatic hydrolysis altered other reagents’ sensitivity.
  144. Barbiturate detection in oral fluid, plasma, and urine Ther Drug Monit, 2011 After separate controlled doses of butalbital, phenobarbital or secobarbital, GC-MS detected the administered barbiturate in the first pooled urine collection.
  145. EMIT dau: methadone false positive with creatinine interference Forensic Sci Int, 2005 Fucci reports creatinine interference on an EMIT dau urine methadone screen.
  146. False positive results for amphetamine in urine of a patient with diabetes mellitus Forensic Sci Int, 2012 This report concerns an unconfirmed urine amphetamine finding in a patient with diabetes. The checker cites it in connection with metformin.
  147. False-positive lysergic acid diethylamide immunoassay screen associated with fentanyl medication Clin Chem, 2002 A hospitalized patient's LSD screening results failed confirmation for both LSD and its major metabolite by LC-MS. The authors associated the unexpected screens with fentanyl medication.
  148. Unusual Drug Test Results for a Patient on Buprenorphine and Naloxone Clin Chem, 2019 The citation identifies a clinical investigation concerning unexpected urine results during buprenorphine/naloxone treatment. The checker cites it as supporting context for naloxone and an oxycodone screen.
  149. [Unusual analytical interference caused by benzathine penicillin G] Acta Otorrinolaringol Esp, 1998 Two emergency patients given benzathine penicillin G had persistently positive urine amphetamine screens. The authors suspected a contribution from the benzathine salt and the enzyme immunoassay.
  150. Evaluation of a Benzodiazepine Immunoassay for Urine Drug Testing in Clinical Specimens J Appl Lab Med, 2024 Roche Benzodiazepines II and a hydrolysis-based LDT detected glucuronidated benzodiazepines better than Benzodiazepines Plus in urine. Results depend on the actual assay and its cutoff.
  151. An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results J Appl Lab Med, 2022 High concentrations of loperamide and N-desmethyl loperamide triggered two fentanyl screens in spiked urine. The metabolite also reacted on CEDIA buprenorphine. Four of five loperamide-containing fentanyl-screen specimens actually contained fentanyl.
  152. Application of the CEDIA 6-MAM assay to routine drugs-of-abuse screening J Anal Toxicol, 2002 All 21 CEDIA 6-MAM positives unconfirmed by GC-MS contained free morphine. The authors left the explanation open. A coincident urine analyte is not isolated causal evidence.
  153. Phencyclidine false positive induced by lamotrigine (Lamictal®) on a rapid urine toxicology screen Int J Emerg Med, 2010 Two patients taking lamotrigine screened positive for PCP on Bio-Rad TOX/See. A broader drug screen was negative in the first case.
  154. Fenfluramine: An Uncommon Cause of False Positive Urine Drug Testing: A Case Report Ann Child Neurol Soc, 2025 A child receiving fenfluramine for Dravet syndrome screened positive for amphetamines. Confirmatory testing detected fenfluramine and excluded amphetamines, documenting a discrepancy at a recommended dose.
  155. A labetalol metabolite with analytical characteristics resembling amphetamines J Anal Toxicol, 1995 GC-MS and a reference standard identified the labetalol metabolite 3-amino-1-phenylbutane in patient urine. This compound reacted on the Abbott TDx and two Syva EMIT amphetamine assays.
  156. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine J Anal Toxicol, 2010 Among 96 urine specimens, the DRI oxycodone screen was evaluated against GC-MS detection of either oxycodone or oxymorphone. A separate morphine-directed screen helped cover other opiates.
  157. Using measured cannabidiol and tetrahydrocannabinol metabolites in urine to differentiate marijuana use from consumption of commercial cannabidiol products Clin Toxicol (Phila), 2021 Cannabis biomarkers were measured in urine after reported use of commercial CBD products. Actual THC metabolites can explain positive results; a urine assay cannot independently verify the particular product’s composition.
  158. Cross-Reactivity of Pantoprazole with Three Commercial Cannabinoids Immunoassays in Urine J Anal Toxicol, 2017 Of eight urine specimens from children beginning pantoprazole, all screened positive on Alere Triage, one on KIMS and none on DRI. Only Alere reacted when the parent drug was added to drug-free urine.
  159. Detectability of Dissociative Psychoactive Substances in Urine by Five Commercial Phencyclidine Immunoassays J Anal Toxicol, 2019 On five PCP screens, 3-MeO-PCP and 4-MeO-PCP reacted, methoxetamine reacted weakly, and ketamine was undetected. Two 3-MeO-PCP overdose urines also screened positive across all five.
  160. Cross-Reactivity of Chloroquine and Hydroxychloroquine With DRI Amphetamine Immunoassay Ther Drug Monit, 2017 High chloroquine concentrations produced positive DRI amphetamine results after an acute ingestion and in spiking experiments. Hydroxychloroquine remained negative on DRI at up to 1,000,000 ng/mL.
  161. False positives in urine methadone screening secondary to tapentadol Emergencias, 2020 Two hospitals identified five patients with tapentadol present by GC-MS and unexpected positive DRI methadone screens. Methadone and EDDP were checked by GC-MS.
  162. [Immunoassay methods used to diagnose patients poisoned with psychoactive substances--analytical and interpretation problems] Przegl Lek, 2012 Four Polish cases were checked in the original. After Tisercin plus ThermalPro, HPLC-DAD identified phenothiazines without amphetamine; the authors implicated phenothiazines on the TCA screen and suspected supplement ingredients on the amphetamine screen. Another patient had ketoprofen, levocetirizine and ciprofloxacin detected, without individual causation established.
  163. Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine/methamphetamine assay Clin Chem, 1989 This historical report names ranitidine and high concentrations of phenylpropanolamine as cross-reactants on the monoclonal EMIT amphetamine/methamphetamine assay.
  164. Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction J Anal Toxicol, 2002 Of 48 presumptive CEDIA LSD positives, 13 were confirmed by HPLC-fluorescence. Drug profiling of unconfirmed urines identified 15 potential interferents, including ambroxol, atracurium, diphenhydramine and lidocaine.
  165. Comparison of an automated and point-of-care immunoassay to GC-MS for urine oxycodone testing in the clinical laboratory J Anal Toxicol, 2006 DRI urine oxycodone testing showed no interference with six named opiates. Two specimens low in free oxycodone contained oxymorphone and oxycodone glucuronide. The POC comparator produced two unconfirmed positives without an identified cause.
  166. Phentermine interference and high L-methamphetamine concentration problems in GC-EI-MS SIM Analyses of R-(-)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride-derivatized amphetamines and methamphetamines† J Anal Toxicol, 2014 The investigators documented phentermine interference with quantitation by a specific chiral derivatization GC-MS method and possible misassignment with high l-methamphetamine. This is separate from an initial immunoassay result.
  167. Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC-MS Analysis J Anal Toxicol, 2022 The carboxy metabolite of CBD did not react on four urine cannabinoid immunoassays. Conversion into THC carboxy metabolite occurred under certain laboratory preparation conditions.
  168. Validation of an enzyme-linked immunosorbent assay screening method and a liquid chromatography-tandem mass spectrometry confirmation method for the identification and quantification of ketamine and norketamine in urine samples from Malaysia J Anal Toxicol, 2009 The original Neogen ketamine urine study found no reactivity in a 10,000 ng/mL comparator challenge that included amphetamines, cocaine and related analytes, benzodiazepine, opioids, PCP and tiletamine. Norketamine reacted weakly at 200 ng/mL.
  169. False-positive EMIT indication of opiates and methadone in a doxylamine intoxication J Clin Chem Clin Biochem, 1983 A patient with doxylamine poisoning tested positive for methadone and opiates on two older EMIT assays. Mass spectrometry excluded methadone, and a separate opiate radioimmunoassay was negative.
  170. In vitro conversion of morphine to 6-acetylmorphine in urine samples during enzymatic hydrolysis Clin Chem, 2014 This publication describes formation of 6-acetylmorphine from morphine during enzymatic treatment of urine in the laboratory.
  171. Challenges of LC-MS/MS ethyl glucuronide analysis in abstinence monitoring of liver transplant candidates Clin Chem Lab Med, 2020 In 1,787 urine specimens, using additional mass transitions and parallel ethyl sulfate measurement overturned 11 apparently elevated EtG findings. Investigators attributed one to bacterial metabolism.
  172. Origin and Interpretation of Low Methamphetamine Levels Found in Amphetamine-Positive Urine Samples: Support for Methylation of Amphetamine as a Minor Metabolic Pathway Drug Test Anal, 2025 Chiral analysis of selected Swedish urine samples found trace methamphetamine with a pattern matching the amphetamine enantiomers. In patients on d-amphetamine the tested medicines contained no methamphetamine, supporting minor metabolic formation.
  173. Unreliable alcohol testing in a shipping safety programme Forensic Sci Int, 2009 Uncooled infected urine formed ethanol and in two glucose-supplemented samples EtG after collection. This is a specimen-handling effect and distinct from swallowed alcohol or antibody cross-reaction.
  174. Appearance of hexahydrocannabinols as recreational drugs and implications for cannabis drug testing - focus on HHC, HHC-P, HHC-O and HHC-H Scand J Clin Lab Invest, 2024 Following HHC’s appearance in Sweden, investigators found HHC metabolites in routine urine samples and reproduced cannabis-immunoassay cross-reactivity with related cannabinoids in spiking experiments.
  175. Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers J Anal Toxicol, 2025 After single therapeutic doses of dexamphetamine or lisdexamfetamine, healthy volunteers excreted measurable amphetamine. The methylphenidate arm measured urinary ritalinic acid instead.
  176. HelloPharmacist. Can Benzocaine Cause A False-Positive For Cocaine? 2022 Our pharmacist’s answer to a reader who asked whether topical benzocaine can cause a false positive for cocaine on an oral swab test. The test makers’ own studies listed with the cocaine entry tested benzocaine in urine and in oral fluid.
  177. HelloPharmacist. Can Hydroxyzine Cause A False Positive For A Benzo? 2022 Our pharmacist’s answer to a reader taking hydroxyzine who asked whether it can make a urine drug test read positive for benzodiazepines. For the urine evidence, see the Lin-Zhi and Thermo Scientific DRI benzodiazepine test inserts. The tricyclic antidepressant result it quotes came from a study of blood serum (Dasgupta et al., Ther Drug Monit 2007).
  178. HelloPharmacist. What Can Cause A False Positive For Cocaine? 2022 Our pharmacist’s answer on what can cause a false positive for cocaine, written for a parent who asked about amoxicillin and hydroxyzine. The patient study it discusses tested amoxicillin. For hydroxyzine, see the Thermo Scientific CEDIA cocaine test’s cross-reactivity guide.
  179. HelloPharmacist. What Drugs Cause Fentanyl False-Positives? 2022 Our pharmacist’s answer on what can make a urine or oral swab test read positive for fentanyl. It lists iloperidone, but the study usually cited for it tested risperidone and its metabolite, not iloperidone (Wang et al., J Anal Toxicol 2014).
  180. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites J Anal Toxicol, 2010 Oxycodone and opiate tests differed in detection of authentic specimens with noroxycodone or norhydrocodone alone. Both compounds are evidence of actual parent opioid exposure.
  181. Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays J Toxicol Clin Toxicol, 2003 Quetiapine-spiked samples and urine from one therapeutic-use and one overdose patient tested positive on Syva and Microgenics TCA methods. Biosite Triage stayed negative in both patient samples and at the concentrations examined.
  182. Presence of rifampicin in urine causes cross-reactivity with opiates using the KIMS method J Anal Toxicol, 1995 This earlier letter specifically reports rifampin-associated urine opiates cross-reactivity on a KIMS assay.
  183. Hightop Fentanyl/Norfentanyl Urine Rapid Test Panel and home-use panel, FDA 510(k) summary K241969 2024 Documents results for fentanyl-related anesthetics on the Hightop rapid panel, including a positive with added alfentanil. It also gives device-specific results for labetalol.
  184. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens J Anal Toxicol, 2003 Urine standards and patient specimens documented differing MDA/MDMA detection by eight stimulant assays, including tests specifically designed to detect amphetamines plus MDMA.
  185. Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records Clin Chem, 2019 Electronic records from ten assays guided urine-spiking experiments. These distinguished genuine interferents, including several on the amphetamine and buprenorphine screens, from co-medication signals; four assay classes yielded newly described reactions.
  186. Hughey and Colby. Central laboratory urine drug screening study, version 1 data and analysis code 2019 For the Abbott MULTIGENT urine TCA screen, the odds ratio for an unconfirmed positive versus a negative after documented hydroxyzine exposure was 1.99 (95% confidence interval 1.68–2.34). Benzocaine’s estimate was 1.2755 (0.99894–1.60294).
  187. Postmortem urine immunoassay showing false-positive phencyclidine reactivity in a case of fatal tramadol overdose Am J Forensic Med Pathol, 2006 Urine after a fatal tramadol overdose tested positive for PCP on EMIT II+, while chromatography found no PCP. Both tramadol and its metabolite produced a signal in separate experiments.
  188. Development of a homogeneous immunoassay for the detection of zolpidem in urine J Anal Toxicol, 2009 A zolpidem-specific urine assay detected unconjugated zolpidem and did not cross-react with the comparator sleep medicines zaleplon or zopiclone. The developers compared clinical urine results with LC-MS/MS.
  189. Quantification of (9R)- and (9S)-hexahydrocannabinol (HHC) via GC-MS in serum/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related substances in serum, urine, and saliva Drug Test Anal, 2024 The study compared the HHC stereoisomers and related cannabinoids across urine, serum and saliva screening methods. Separated the urine findings from driver serum prevalence and recorded the nonreactive analogues.
  190. Immunalysis SEFRIA Fentanyl Urine Enzyme Immunoassay, FDA 510(k) decision summary K161216 2017 Documents the responses of the SEFRIA fentanyl assay to individual compounds at specified challenge concentrations, including positive results with several antidepressants.
  191. Interference of Selected Clinical Medicines on DRI and TDx Immunoassays of Morphine and Methamphetamine in Urine 1999 In laboratory comparisons of DRI and TDx reagents, trimethobenzamide interfered with the DRI methamphetamine result. The paper distinguished antibody-related effects from optical interference.
  192. False-positive tricyclic antidepressant results in diphenhydramine overdose: a report of two cases and a literature review BMC Neurol, 2026 Two adolescents with diphenhydramine overdose screened positive for TCAs on SIGNIFY ER despite urinary parent-drug concentrations below 100 µg/mL. Spiked urine was negative at 100 and positive at 500 µg/mL.
  193. Increased False Positives vs Increased Interference Flags: Comparison of 2 Ethyl Glucuronide Immunoassays J Appl Lab Med, 2026 ARK and Immunalysis EtG assays differed in the frequency of false positives and instrument interference flags in patient samples compared with LC–MS/MS.
  194. Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes Am J Public Health, 1999 This tobacco biomarker study compared nicotine with minor tobacco alkaloids in urine. Anabasine and anatabine offered additional evidence of tobacco use when nicotine replacement could explain cotinine.
  195. Cross-reactivity of naloxone with oxycodone immunoassays: implications for individuals taking Suboxone Clin Chem, 2009 This letter specifically reports naloxone cross-reactivity with oxycodone immunoassays and addresses its relevance to buprenorphine/naloxone products.
  196. Identification and quantitation of alkaloids in coca tea Forensic Sci Int, 1996 The investigators found cocaine and other alkaloids in prepared coca-leaf teas from Peru and Bolivia. Benzoylecgonine appeared in urine after one individual drank each tea on separate occasions.
  197. Evaluation of the Cedia heroin metabolite (6-AM) immunoassay with urine specimens from A criminal justice drug-testing program J Anal Toxicol, 2005 The 2005 CEDIA heroin-metabolite assay had high agreement with GC-MS in criminal-justice specimens. High concentrations of morphine, hydromorphone, codeine, hydrocodone, oxycodone and pentazocine also triggered it in laboratory challenges.
  198. Trimethobenzamide cross-reacts in immunoassays of amphetamine/methamphetamine Clin Chem, 1993 The authors reported trimethobenzamide interference in amphetamine/methamphetamine immunoassays.
  199. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse J Anal Toxicol, 1995 Tolmetin interfered optically with several EMIT tests, sometimes causing an instrument alarm or suppressing a positive. The investigators separately found potential false-positive benzodiazepine responses from high concentrations of five NSAIDs on TDx.
  200. Case Reports of Aripiprazole Causing False-Positive Urine Amphetamine Drug Screens in Children Pediatrics, 2015 Two toddlers had positive urine amphetamine screens following suspected aripiprazole ingestion. GC-MS found no amphetamines in their blood or urine.
  201. False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate Ther Drug Monit, 2012 During fenofibrate treatment, one patient repeatedly screened positive on CEDIA amphetamine/ecstasy and DRI MDMA tests. Three specimens failed GC-MS confirmation, and the screens turned negative after fenofibrate was stopped.
  202. Automated extraction and LC-MS-MS analysis of 11-nor-9-carboxy-tetrahydrocannabinol isomers and prevalence in authentic urine specimens J Anal Toxicol, 2024 Among 2,939 urines selected for a positive cannabinoid immunoassay, nearly one-third contained only delta-8 THC-COOH at confirmation. The study used isomer-selective LC-MS/MS at 15 ng/mL.
  203. Tentative identification of a labetalol metabolite in the investigation of a false-positive amphetamine immunoassay result using targeted and untargeted high-resolution mass spectrometry Clin Chem Lab Med, 2026 Urine from a pregnant patient taking labetalol screened positive on a nal von minden AMP1000 cassette and negative on CEDIA. High-resolution mass spectrometry tentatively identified a previously described minor labetalol metabolite and excluded two lookalike compounds.
  204. Kinetics of primidone metabolism and excretion in children Clin Pharmacol Ther, 1977 Children taking primidone long term excreted phenobarbital in urine. This documents a genuine barbiturate metabolite after primidone treatment.
  205. The urinary excretion of gamma-hydroxybutyric acid in man J Pharm Pharmacol, 2001 After one volunteer took two different doses of the sodium salt of GHB, free GHB appeared in urine. Sodium oxybate can therefore supply the analyte measured by a GHB test.
  206. Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines J Anal Toxicol, 2011 A fortified-urine study found 4-MTA recognition by stimulant ELISAs. Ten other named 2C/DO analogues failed to reach a positive result even at 50,000 ng/mL. These were designer compounds, without treatment exposure.
  207. A case of diphenhydramine intoxication showing prolonged false positive tricyclic antidepressant in the urine assay Asian Biomed (Res Rev News), 2023 After a diphenhydramine overdose, the patient's urine TCA screen remained positive at 60 hours and was negative at 90 hours.
  208. False-Positive Phencyclidine (PCP) Result on 11-Panel Urine Drug Screen (UDS) in a 17-Year-Old Adolescent with Long-Term Venlafaxine Use Case Rep Psychiatry, 2023 An adolescent taking maintenance venlafaxine extended release had an unexpected PCP result on an 11-panel urine screen, extending the clinical reports beyond overdose.
  209. Does Lidocaine Cause False Positive Results on Cocaine Urine Drug Screen? J Med Toxicol, 2019 Among 121 urine samples containing lidocaine after medical treatment, none screened positive for cocaine. Most also contained the lidocaine metabolite MEGX.
  210. The clinical impact of a false-positive urine cocaine screening result on a patient's pain management Pain Med, 2015 A positive urine cocaine screen affected a patient’s cancer pain plan. GC-MS found neither cocaine nor benzoylecgonine, and the team reconsidered treatment.
  211. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans Ther Drug Monit, 2004 After controlled oral sustained-release d-methamphetamine, GC-MS measured both methamphetamine and its metabolite amphetamine in urine. The relative amount of amphetamine increased over time.
  212. Abbott propoxyphene assay: evaluation and comparison of TDx FPIA and GC/MS methods J Anal Toxicol, 1993 Abbott TDx measured propoxyphene and its major metabolite, norpropoxyphene, with concentration-dependent recognition. The evaluation included urine and other specimens.
  213. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry J Anal Toxicol, 2005 In Roche KIMS spiked urine, beta-glucuronidase improved response to lorazepam, oxazepam and temazepam glucuronides. The result addresses detection of actual benzodiazepine exposure.
  214. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use Clin Chim Acta, 2020 Definitive testing found THC metabolites in five people taking dronabinol. Detection of those metabolites is compatible with prescribed delta-9 THC.
  215. Efavirenz does not cause false-positive urine cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy Med J Malaysia, 2013 One of 51 efavirenz-treated participants screened positive using Abbott AxSYM Cannabinoids. That participant reported cannabis use the day before. No unexplained positive was observed on this kit.
  216. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine J Anal Toxicol, 1997 RapiTest MOP recognized codeine and ethylmorphine and RapiTest MET recognized amphetamine in the urine evaluation. The paper does not give universal concentration thresholds.
  217. Development and validation of a high-performance liquid chromatography method for the evaluation of niflumic acid cross-reactivity of two commercial immunoassays for cannabinoids in urine J Anal Toxicol, 2010 Niflumic acid triggered the cannabinoid KIMS test in spiked urine and in all 55 specimens from five treated participants. The corresponding EMIT results were negative.
  218. The antispasmodic drug mebeverine leads to positive amphetamine results by fluorescence polarization immunoassay (FPIA)--studies on the toxicological analysis of urine by FPIA and GC-MS J Anal Toxicol, 2001 Following a single oral dose of mebeverine, urine screened positive on an amphetamine FPIA. GC-MS identified related mebeverine metabolites that could explain the antibody response.
  219. Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent details 2009 Tables A–R compare manufacturer and literature results for individual compounds on 18 test families. Individual reagents sometimes gave different results for the same drug. The accompanying register preserves those cells and the paper’s overall classifications. Tab Q includes hydroxyzine and other compounds tested on propoxyphene reagents.
  220. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine BMC Emerg Med, 2009 The authors compared manufacturers’ assay cross-reactivity data and investigated PCP and TCA screens at their center using GC-MS. The paper distinguishes chemical similarity from measured reactivity.
  221. Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite J Appl Lab Med, 2020 Cannabinol added to urine triggered two THC-metabolite immunoassays and increased the signal from low amounts of genuine THC metabolite on EMIT II Plus.
  222. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine Anal Bioanal Chem, 2014 The synthetic-cannabinoid urine screen reacted with MAM-2201 and JWH-122 metabolites while missing UR-144 metabolites. This was a synthetic-cannabinoid-specific test.
  223. Evaluating solriamfetol interference in urine amphetamine immunoassays: a four-platform comparison J Anal Toxicol, 2026 The publisher's extract identifies a head-to-head solriamfetol comparison on Beckman EMIT II Plus, Vitros AMPH, Abbott Alinity AMP/MET and Roche Amphetamines II.
  224. False positive urine amphetamine immunoassay due to solriamfetol Sleep Med, 2023 A clinical case prompted a solriamfetol challenge on an amphetamine immunoassay. Fortified urine screened positive at 200 and 2,000 µg/mL, and targeted mass spectrometry excluded amphetamines.
  225. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine J Anal Toxicol, 1990 Fortified urine showed MDMA and MDEA recognition by two stimulant tests, with Syva EMIT responding only at the highest tested level. These compounds are related stimulant analytes.
  226. Evaluation of the interference of lamotrigine on the analysis of synthetic cannabinoids in urine by the immunoassay method Scand J Clin Lab Invest, 2021 Participants taking lamotrigine had a synthetic-cannabinoid K2/1 immunoassay signal with negative targeted LC-MS/MS. Both spiking and mixing experiments supported interference.
  227. False-positive results in urine drug screening in healthy volunteers participating in phase 1 studies with efavirenz and rifampin Ther Drug Monit, 2006 The title identifies false-positive urine drug screens during phase 1 studies involving efavirenz and rifampin. It is a lead for interpreting a multi-drug exposure.
  228. A Comparative Analysis of Two Commonly Used FDA-Approved Immunoassays for Fentanyl Detection J Appl Lab Med, 2024 Table 1 and the discussion show concentration-dependent discordance for actual prescribed fentanyl and its metabolite. The investigators did not identify a medication that caused the false-positive specimens.
  229. A case of false positive opiate immunoassay results from rifampin (rifampicin) treatment Pract Lab Med, 2023 A child receiving rifampin had a positive Roche KIMS opiate screen and negative LC-MS/MS. Adding rifampin to drug-free urine reproduced the discrepancy.
  230. False-positive results in the detection of methadone in urines of patients treated with psychotropic substances Clin Chem, 2005 The authors reproduced methadone signals with several psychotropic drugs in urine on a reformulated Roche KIMS assay, including cyamemazine, alimemazine, levomepromazine, chlorpromazine, clomipramine and thioridazine. Several other tested drugs stayed negative.
  231. False positive phencyclidine result on urine drug testing: a little known cause BJPsych Bull, 2015 Two psychiatric rehabilitation patients taking venlafaxine had repeat positive PCP screens. The authors reported venlafaxine as the only medication common to both.
  232. False-positive methadone urine drug screen in a patient treated with quetiapine Acta Clin Croat, 2012 A hospitalized patient receiving quetiapine and risperidone developed an unexpected positive Roche COBAS Integra methadone screen two weeks after admission.
  233. Enzyme linked immunosorbent assay for detecting benzodiazepines in urine Analyst, 1996 Mouse anti-oxazepam ELISA did not recognize flurazepam or chlordiazepoxide at concentrations reported for urine. The nitrazepam administration experiment was in a greyhound.
  234. False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology J Anal Toxicol, 2020 Two metoprolol poisonings yielded unconfirmed amphetamine/MDMA screens. Metoprolol triggered both Abbott MULTIGENT assays in spiked urine, whereas the two metabolites studied reacted only with the amphetamine assay.
  235. UPLC-ESI-Q-TOF-MS(E) identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects J Pharm Biomed Anal, 2014 Mass spectrometry identified five urinary metabolites in people using methoxyisoflavone, clarifying the supplement’s metabolism.
  236. Methylene Blue-Induced False-Positive Amphetamine Results in Urine Drug Screening: Two Case Reports Ther Drug Monit, 2026 The paper reports two cases of unexpected positive urine amphetamine screens associated with methylene blue.
  237. Isometheptene cross reacts in the EMIT amphetamine assay Clin Chem, 1987 This letter names isometheptene as a cross-reactant on an EMIT amphetamine assay.
  238. False-positive RIA for methamphetamine following ingestion of an Ephedra-derived herbal product J Anal Toxicol, 2003 A report describes a methamphetamine radioimmunoassay positive after use of an Ephedra-derived herbal preparation.
  239. Development and Clinical Validation of a Sensitive Lateral Flow Assay for Rapid Urine Fentanyl Screening in the Emergency Department Clin Chem, 2020 An investigational fentanyl lateral-flow assay detected fentanyl and norfentanyl, with low but measurable reactivity to risperidone and 9-hydroxyrisperidone (paliperidone). ED samples were compared with LC-MS/MS.
  240. False-positive immunochemical screen for methadone attributable to metabolites of verapamil Clin Chem, 1998 Investigators traced a positive methadone immunoassay to verapamil metabolites on the earlier reagent. This report provides the original attribution referenced in the manufacturer's subsequent reply.
  241. Performance characteristics of 7-aminoflunitrazepam specific enzyme-linked immunosorbent assays J Anal Toxicol, 2005 Cozart and Immunalysis assays specific to 7-aminoflunitrazepam showed significant diazepam recognition. Reagent lot, urine dilution and other benzodiazepines influenced quantitative comparison.
  242. Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups J Anal Toxicol, 2013 The full NexScreen study observed a TCA positive with urine spiked with 1,000 ng/mL cyclobenzaprine. Separate low-level challenges with several medicines did not interfere on either cup; pooled patient samples cannot isolate individual causes.
  243. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH] Zhonghua Yi Xue Za Zhi (Taipei), 1991 The authors specifically report EMIT d.a.u. amphetamine false-positive reactions with fenfluramine and diethylpropion. Their GC ion-trap urine study also found other concurrent drugs, which they did not identify as causal.
  244. Lin-Zhi International benzodiazepine enzyme immunoassay. Hitachi 717 instructions, revision 14 2025 Lin-Zhi warns that hydroxyzine can produce a false positive above 16,000 ng/mL at the 200 ng/mL urine benzodiazepine cutoff and above 24,000 ng/mL at the 300 ng/mL cutoff. Cetirizine is listed separately.
  245. Lin-Zhi International. LZI Amphetamines Enzyme Immunoassay for Hitachi 717. Instructions for use, revision 10 2024 Lin-Zhi lists negative challenge results for mephentermine and phenmetrazine on the Hitachi 717 amphetamines assay. Other reagents have reported different responses.
  246. Unusual false-positive case of urinary screening for buprenorphine J Clin Lab Anal, 2011 An unusually high-buprenorphine urine specimen caused a false-positive immunoassay result for the next specimen on the instrument.
  247. Ranitidine interference with standard amphetamine immunoassay Clin Chim Acta, 2015 Urine fortified with ranitidine produced a positive Beckman Coulter AMPH result at 160 micrograms/mL. Siemens EMIT II Plus showed no interference in the same investigation.
  248. False positive ketamine urine immunoassay screen result induced by quetiapine: A case report J Formos Med Assoc, 2017 Two people using quetiapine had urine ketamine screens that failed confirmatory testing.
  249. Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine J Anal Toxicol, 2010 MDMA-positive EMIT II ecstasy specimens contained trazodone and mCPP without LC-MS/MS-confirmed MDMA. Separate standards for trazodone, mCPP and TFMPP reacted with the same assay.
  250. Interference of thioridazine (Mellaril) in identification of phencyclidine Clin Chem, 1996 The second case involved urine containing thioridazine and mesoridazine. The EMIT II PCP screen was positive, and GC-MS did not confirm PCP.
  251. Multiplex assay of amphetamine, methamphetamine, and ecstasy drug using CEDIA technology J Anal Toxicol, 2002 The combined CEDIA Amphetamines/Ecstasy was designed to recognize multiple related drugs. Reported analytical responses include MDA, MDMA, MDEA, MBDB, BDB, PMA and PMMA.
  252. Inhalation and oral administration of HHC products - Quantification of (9R)-, (9S)-Hexahydrocannabinol and metabolites in plasma and detectability in on-site drug tests for urine and oral fluid Forensic Sci Int, 2025 After oral or inhaled HHC product exposure, the urine DrugScreen cannabinoid test with a 25 ng/mL THC-COOH cutoff produced positive results. Plasma and oral-fluid findings were evaluated separately.
  253. Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens J Mass Spectrom Adv Clin Lab, 2023 Urine studies of two high-sensitivity benzodiazepine immunoassays showed the effects of hydrolysis on lorazepam detection and documented authentic specimens missed despite measurable analyte.
  254. False-positive urine phencyclidine immunoassay screen result caused by interference by tramadol and its metabolites Ann Emerg Med, 2012 Two people who developed seizures after tramadol misuse had erroneous PCP urine screens. In vitro testing supported an effect of tramadol and a metabolite.
  255. LZI Fentanyl Enzyme Immunoassay, FDA 510(k) decision summary K181159 2018 In the Lin-Zhi submission, adding 40,000 ng/mL dextromethorphan to drug-free urine produced a positive fentanyl result.
  256. False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV) Drug Test Anal, 2013 The report attributes an unexpected PCP immunoassay result to the synthetic cathinone MDPV.
  257. Kavain Interference with Amphetamine Immunoassay J Anal Toxicol, 2020 Three CEDIA amphetamine-positive urines contained kavain and no confirmed amphetamine-type drugs. Three kava preparations and an authentic kavain standard also reacted when added to urine.
  258. [Treatment of Dravet disease and false urine testing with ecstasy: a little-known interference] Ann Biol Clin (Paris), 2025 A child receiving stiripentol had two positive ecstasy screens with negative GC-MS confirmation. A third screen was negative, and the three urine stiripentol concentrations fell on the predicted sides of the reagent's cross-reactivity threshold.
  259. Bupivacaine Metabolite Can Interfere with Norfentanyl Measurement by LC-MS/MS J Appl Lab Med, 2022 After epidural analgesia, a bupivacaine metabolite interfered with measurement of norfentanyl on a particular urine LC–MS/MS method. The study identified a way to distinguish them.
  260. False-positive urine drug screen for oxycodone among opioid-dependent patients on oral naltrexone: A case series study Asian J Psychiatr, 2024 This indexed case series reports unexpected urine oxycodone screens in opioid-dependent patients taking oral naltrexone.
  261. An enzyme-linked immunosorbent assay for urinary screening of fentanyl citrate abuse Ann Clin Lab Sci, 1995 A 1995 urine fentanyl ELISA detected administered surgical fentanyl, including the low-dose cohort, and reacted only weakly with norfentanyl. Other analgesics are not named in the abstract.
  262. Methylphenidate produces a false-positive urine amphetamine screen Pediatr Emerg Care, 2002 The authors reported a positive urine amphetamine screen associated with methylphenidate. This is the historical clinical report behind that pairing.
  263. Development of an enzyme-linked immunosorbent assay for fentanyl and applications of fentanyl antibody-coated nanoparticles for sample preparation J Pharm Biomed Anal, 2006 An experimental anti-fentanyl ELISA recognized several fentanyl analogues and showed very low response to others. The method was validated for urine and serum; the abstract does not specify a separate challenge matrix for every antibody response.
  264. Are false-positive phencyclidine immunoassay instant-view multi-test results caused by overdose concentrations of Ibuprofen, metamizol, and dextromethorphan? Ther Drug Monit, 2007 The letter investigates an Instant-View PCP result in connection with overdose concentrations of ibuprofen, metamizole and dextromethorphan.
  265. One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry J Anal Toxicol, 2016 The authors examined 100 unconfirmed amphetamine or MDMA screens with high-resolution mass spectrometry and separately tested candidate standards. The work helps distinguish bupropion metabolite and other assay reactions from drugs merely present in selected specimens.
  266. Common herbal supplements did not produce false-positive results on urine drug screens analyzed by enzyme immunoassay J Anal Toxicol, 2004 In this supplement study, one participant using ginkgo had a positive amphetamine screen. GC-MS confirmed amphetamine itself, so the result did not demonstrate ginkgo interference.
  267. Cross-reactivity of urine opiates screening assays with dextromethorphan Clin Chim Acta, 2025 A high-dose dextromethorphan case and laboratory challenges with dextromethorphan and dextrorphan showed that some urine opiate screens can react at high concentrations.
  268. Structural elucidation of an uncommon phenylethylamine analogue in urine responsible for discordant amphetamine immunoassay results J Anal Toxicol, 2000 Synthesis and spectral comparison identified N-ethyl-4-methoxyamphetamine in a urine specimen positive by FPIA and negative on Triage 8. Their decision cutoffs differed.
  269. Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning J Toxicol Clin Toxicol, 1990 As part of a clinical study, the authors investigated flumazenil as a potential interferent. They found no reaction on the EMIT, TDx or radioimmunoassay benzodiazepine methods tested.
  270. Accidental intoxications in toddlers: lack of cross-reactivity of vilazodone and its urinary metabolite M17 with drug of abuse screening immunoassays BMC Clin Pathol, 2019 Two toddlers screened positive for amphetamines after vilazodone exposure. Neither vilazodone nor its M17 metabolite reproduced the signal on the two urine assays tested, even at 100 micrograms/mL.
  271. Synthetic sweetener cyclamate as a potential source of false-positive amphetamine results in the TDx system Clin Chem, 1991 The authors reported a possible connection between the sweetener cyclamate and an amphetamine result on the Abbott TDx system. The checker identifies urinary cyclohexylamine as the proposed link.
  272. [Phencyclidine in urine toxicology screening: a dangerous false positive] An Pediatr (Barc), 2011 A child had a positive PCP screen on the Linear Chemicals MPD Screen 12 after therapeutic ibuprofen. GC-MS subsequently detected ibuprofen and excluded PCP.
  273. Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry Int J Legal Med, 1990 A therapeutic dose of pholcodine produced opiate-positive urine screens on three immunoassay types. Targeted GC-MS detected parent pholcodine and its metabolites.
  274. Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) in toxicological analysis. Studies on the detection of clobenzorex and its metabolites within a systematic toxicological analysis procedure by GC-MS and by immunoassay and studies on the detection of alpha- and beta-amanitin in urine by atmospheric pressure ionization electrospray LC-MS J Chromatogr B Biomed Sci Appl, 1997 After clobenzorex ingestion, amphetamine formed in the body accounted for urine TDx positivity. The parent did not react in the assay studied.
  275. Coca tea consumption causes positive urine cocaine assay Eur J Emerg Med, 2006 All five volunteers who drank coca tea screened positive for cocaine metabolites on fluorescence polarization immunoassay.
  276. Lamotrigine Cross-Reactivity With Phencyclidine in Rapid Urine Toxicology in a Research Study Prim Care Companion CNS Disord, 2018 A research participant taking lamotrigine twice screened positive for PCP on the six-panel iCup. Concurrent mass spectrometry found no PCP.
  277. Interpretation of GC-MS opiate results in the presence of pholcodine Forensic Sci Int, 2002 The validated GC-MS study found free morphine in urine after pholcodine administration. This concerns actual detected morphine and the interpretation of a specific confirmation workflow.
  278. False-positive EMIT II opiates from ofloxacin Ther Drug Monit, 1997 Ofloxacin produced positive EMIT II opiate results in spiked urine, in three patients taking therapeutic doses and in two volunteers. Ciprofloxacin and norfloxacin patient samples tested negative on that reagent.
  279. MEDTOX Diagnostics. PROFILE-V MEDTOXScan Drugs of Abuse Test System, FDA 510(k) summary K091454 2009 In fortified urine, chlorpromazine, carbamazepine and carbamazepine-10,11-epoxide each tested negative at 100,000 ng/mL on the 300 ng/mL desipramine-calibrated TCA channel.
  280. Urinary tricyclic antidepressant screening: comparison of results obtained with Abbott FPIA reagents and Syva EIA reagents J Anal Toxicol, 1990 Compared Abbott ADx and adapted Syva ETS urine TCA assays, including clomipramine. The source states that some non-TCAs reacted at 1,000 ng/mL, without identifying them in the PubMed abstract.
  281. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays Arch Pathol Lab Med, 2006 Among 22 patients with promethazine detected in serum, a monoclonal EMIT amphetamine assay gave unconfirmed positives in 36%. Other assays showed less interference from promethazine and chlorpromazine.
  282. Interpreting tricyclic antidepressant measurements in urine in an emergency department setting: comparison of two qualitative point-of-care urine tricyclic antidepressant drug immunoassays with quantitative serum chromatographic analysis J Anal Toxicol, 2007 Two urine TCA devices detected several prescribed tricyclics, often missed clomipramine, and differed in their response to cyclobenzaprine. Cyclobenzaprine false positives were more frequent on Biosite Triage.
  283. A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse J Anal Toxicol, 2012 A 149-specimen comparison found better agreement with LC-MS/MS for Lin-Zhi buprenorphine EIA than for CEDIA. The authors also identified chloroquine and hydroxychloroquine interference with CEDIA.
  284. Desipramine and amantadine causing false-positive urine test for amphetamine Ann Emerg Med, 1993 This case report names both desipramine and amantadine in connection with a false-positive urine amphetamine result.
  285. Doxepin causing false-positive urine test for amphetamine Ann Emerg Med, 1993 Merigian and colleagues reported a false-positive urine amphetamine test associated with doxepin in a 1993 case letter.
  286. Methoxyisoflavone and urine cannabinoid screening: evidence of a poorly known cross-reactivity 2012 Three volunteers taking a methoxyisoflavone supplement had positive cannabinoid screens after repeated doses. The investigators identified its hydroxy metabolite in urine.
  287. [Urine toxicological screening method using an immunoenzymatic assay based on a biochip array technology: comparative study with immunochromatography and Liquid chromatography–mass spectrometry] Ann Biol Clin (Paris), 2022 The French Multistat study proposes O-desmethylvenlafaxine as a possible explanation for unconfirmed tramadol urine results. Co-medication review did not identify a particular drug behind the other buprenorphine or oxycodone discrepancies.
  288. A Case of False-positive Amphetamine Results on Urine Toxicology Testing Secondary to Imatinib J Addict Med, 2021 An expectant patient restarting imatinib had repeated presumptive amphetamine screens with negative definitive maternal urine GC-MS.
  289. Validation of the Immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine J Anal Toxicol, 2006 An Immunalysis urine buprenorphine ELISA detected both buprenorphine and norbuprenorphine. Codeine, dihydrocodeine, tramadol, morphine, propoxyphene, methadone and EDDP did not cross-react at the two concentrations tested.
  290. The detection of 6-monoacetylmorphine in urine, serum and hair by GC/MS and RIA Forensic Sci Int, 1995 This RIA gave excessive 6-MAM estimates in specimens containing authentic 6-MAM. The authors attributed the difference to morphine and its 6-glucuronide. The selected positive specimens cannot show that either alone caused an unconfirmed screen.
  291. Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine J Anal Toxicol, 2014 An ELISA specifically designed for UR-144/XLR-11 recognized several hydroxylated metabolites better than the parent compounds in urine. This is expected recognition on a dedicated assay.
  292. Urinary false-positive ecstasy screening by Mebeverine Metabolite: a confirmatory study and controlled administration Acta Clin Belg, 2026 Three patients taking therapeutic mebeverine had positive MDMA strips with GC-MS negative for MDMA and MDA. A controlled dose reproduced the result, and mebeverine O-desmethyl-butanol was detected in those specimens.
  293. A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry J Anal Toxicol, 2006 Patient comparisons found weak class-opiate recognition of oxycodone by Instant-View and hydrocodone/hydromorphone by TesTcup. The abstract attributes amphetamine false positives to sympathomimetics as a group.
  294. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles Clin Chem, 2002 The authors developed an LC-MS/MS method that separately measured nicotine, cotinine, hydroxycotinine and minor alkaloids in urine or serum. This supports interpretation of exposure in patients using nicotine replacement.
  295. ∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods J Anal Toxicol, 2023 Urine fortified with delta-8-THC-COOH produced 87% to 112% cross-reactivity at the 50 ng/mL cutoff across three cannabinoid immunoassays. No participating certified laboratory falsely reported confirmed delta-9-THC-COOH.
  296. Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates? Clin Toxicol (Phila), 2015 Among 11 patients with therapeutic tapentadol use, investigators observed no false-positive methadone or general opiates screens on Syva EMIT II. Other opioid prescriptions accounted for the genuine positive results.
  297. Phencyclidine False Positive Result Induced by LamoTRIgine on the PROFILE-V MEDTOXScan Drugs of Abuse Test System J Emerg Nurs, 2019 This clinical letter specifically names the PROFILE-V MEDTOXScan as a PCP test implicated during lamotrigine exposure, contributing a second device family to the record.
  298. Norbuprenorphine Interferences in Urine Drug Testing LC-MS-MS Confirmation Methods from Quetiapine Metabolites J Anal Toxicol, 2022 Quetiapine metabolites interfered with reporting norbuprenorphine in certain LC–MS/MS methods. The authors found alternate measurements that resolved the problem.
  299. Evaluation of a Newly Formulated Enzyme Immunoassay for the Detection of Hydrocodone and Hydromorphone in Pain Management Compliance Testing J Anal Toxicol, 2016 Lin-Zhi’s hydrocodone assay was designed to detect hydrocodone and hydromorphone. Urine challenges showed responses to other opioids at high concentrations, with some results changing between 100 and 300 ng/mL cutoffs.
  300. False-Positive Urine Screening for Benzodiazepines: An Association with Sertraline?: A Two-year Retrospective Chart Analysis Psychiatry (Edgmont), 2009 In a two-year chart review, 26 of 98 patients whose benzodiazepine screens failed GC-MS confirmation and who lacked a benzodiazepine prescription had a sertraline prescription.
  301. Neogen. Gabapentin forensic ELISA instructions for kits 182419 and 182415 The parent drug pregabalin showed 1.1% cross-reactivity in the kit’s buffer displacement experiment. Pregabalin methyl ester was a separate challenge compound.
  302. Evaluation of KIMS immunoassays on a cobas c 501 analyzer for drugs of abuse and ethyl glucuronide testing in urine for forensic abstinence control Drug Test Anal, 2017 The modified Roche cobas c 501 urine methods were challenged with medicines, metabolites and newer psychoactive substances. Table 4 reports assay-specific relative responses for the eight target groups.
  303. Response of CEDIA amphetamines assay after a single dose of bitter orange Ther Drug Monit, 2006 Six men took a single bitter-orange product standardized to synephrine. All collected urines were negative on CEDIA Amphetamines. This cannot be generalized to other extracts or regimens.
  304. False-positive urine amphetamine screen with ritodrine Clin Chem, 1989 The letter describes a false-positive amphetamine urine screen associated with ritodrine.
  305. ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen® "Amphetamine" and "Methamphetamine/MDMA" Kits J Anal Toxicol, 2016 All 30 separately fortified compounds failed to trigger either Neogen kit in the urine arm up to 10,000 ng/mL. Blood and oral fluid differed. The two kit results are assigned to their actual target channels.
  306. [The false positive reaction of the Triage panel drug-of-abuse by herbal drugs ma-huang (Ephedra sinica (Ephedraceae))] Nihon Hoigaku Zasshi, 2001 After two unexpected Triage amphetamine screens prompted an investigation, urine from seven volunteers given ma-huang also screened positive. Follow-up chromatography supported an ephedra-related false positive.
  307. Comparison of assay methods for benzodiazepines in urine. A receptor assay, two immunoassays, and gas chromatography-mass spectrometry Am J Clin Pathol, 1997 A comparison of 127 urine samples found that a sertraline metabolite interfered with the historical CEDIA benzodiazepine assay, unlike the two comparison methods.
  308. Oxaprozin interference with urinary benzodiazepine immunoassays and noninterference with receptor assay J Anal Toxicol, 1999 This published letter explicitly reports urine oxaprozin interference on benzodiazepine immunoassays with no receptor-assay interference. The citation does not establish a particular brand, threshold or patient frequency.
  309. SIGNIFY™ ER tricyclic antidepressant false positives in diphenhydramine overdose cases J Anal Toxicol, 2026 Four of 11 diphenhydramine overdose cases without concomitant TCA use had a positive SIGNIFY ER TCA result. Patient concentrations and fortified-urine experiments implicated diphenhydramine N-oxide and its N-glucuronide.
  310. Right coronary anomaly in a patient with myocarditis and cardiac arrest: a case report Eur Heart J Case Rep, 2018 The case narrative explicitly attributes an unconfirmed urine LSD screen to fentanyl given in the emergency department several hours earlier. Fentanyl was not independently isolated or challenged on the patient's reagent.
  311. Drug screening by enzyme immunoassay (EMIT) and thin-layer chromatography (Drug Skreen) J Clin Chem Clin Biochem, 1977 The investigators compared EMIT with thin-layer chromatography in 300 urine samples. Their amphetamine specificity experiments identified reactivity from fenethylline, ephedrine, propylhexedrine and fenfluramine. Methylphenidate gave no reaction.
  312. A biotin-avidin based screening test for methamphetamine in urine J Pharm Biomed Anal, 1992 The prototype methamphetamine assay showed less than 7% response to amphetamine. No individual target-free positive threshold is reported.
  313. Metabolites of chlorpromazine and brompheniramine may cause false-positive urine amphetamine results with monoclonal EMIT d.a.u. immunoassay Clin Chem, 1992 This letter identifies brompheniramine and chlorpromazine metabolites as possible causes of positive urine amphetamine results on monoclonal EMIT d.a.u.
  314. Commercial Ethyl Glucuronide (EtG) and Ethyl Sulfate (EtS) Testing is Not Vulnerable to Incidental Alcohol Exposure in Pregnant Women Subst Use Misuse, 2016 Five pregnant and five postpartum nurses used alcohol mouthwash and hand sanitizer. No specimen met the study’s commercial combined EtG/EtS reporting criteria.
  315. One-Step Tricyclic Antidepressants MonlabTest urine cassette. Instructions for use, CHEM-7013C-40 2023 The dedicated urine TCA cassette listed benzocaine as nonreactive through 100 µg/mL in its specificity experiment. The test used a 1,000 ng/mL nortriptyline cutoff.
  316. Efavirenz interference in urine screening immunoassays for tetrahydrocannabinol Ann Clin Biochem, 2012 Of 30 patients receiving efavirenz, 28 tested positive on Rapid Response THC strips. GC-MS and the three comparison screens were negative in all 30. Removing glucuronides eliminated the rapid-strip reaction.
  317. Identification of hydrocodone in human urine following controlled codeine administration J Anal Toxicol, 2000 In controlled dosing and a postoperative case, GC-MS found small amounts of hydrocodone in some urine containing much more codeine. This supplies a metabolic explanation for confirmed hydrocodone after codeine use.
  318. Comparative performance of methadone urine immunoassays based on real-world data reveals assay interference J Anal Toxicol, 2026 A routine-laboratory comparison found fewer unconfirmed positive methadone screens with Architect MULTIGENT than Roche MDN2. The medication histories of patients with unconfirmed Roche results frequently listed quetiapine or vortioxetine.
  319. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay Eur J Clin Chem Clin Biochem, 1997 Urine from patients taking buflomedil and urine fortified with the parent drug gave positive results on the monoclonal EMIT amphetamine/methamphetamine assay. The polyclonal assay remained negative.
  320. Multianalyte assay system developed for drugs of abuse Clin Chem, 1993 The full Abbott Advisor study found amphetamine-line reactivity for phenethylamine and PCP-line reactivity for meperidine and trihexyphenidyl. All three required 100 mg/L in fortified urine and were negative at 10 mg/L.
  321. Prevalence of 3,4-Methylenedioxy-α-Pyrrolidinohexanophenone (3,4-MDPHP) in 465 Suspected Intoxication Cases and Cross-Reactivity Evaluation in an Ecstasy Immunoassay J Appl Lab Med, 2026 In a series of suspected new psychoactive substance intoxications, unmodified 3,4-MDPHP did not trigger the Syva EMIT II Plus urine ecstasy assay. Results from patient specimens suggested a contribution from metabolites.
  322. Performance of Xylazine Qualitative Immunoassays Designed for Drug Checking in Urine Samples J Addict Med, 2026 In 106 urine samples, two xylazine strips designed for drug checking agreed well with quantitative LC-MS/MS at their own high thresholds but missed many lower-level exposures.
  323. LC-MS-MS confirmation of 11-nor-9-carboxy-tetrahydrocannabinol (Δ8, Δ9, Δ10) and hexahydrocannabinol metabolites in authentic urine specimens J Anal Toxicol, 2025 The delta-10 THC carboxy isomer (6aR,9R) reacted like the delta-9 calibrator on EMIT II Plus. All 77 urine specimens containing delta-10-THC-COOH also contained delta-9-THC-COOH.
  324. Cross-reactivity of the CEDIA buprenorphine assay with opiates: an Austrian phenomenon? Int J Legal Med, 2005 A CEDIA buprenorphine assay showed cross-reactivity at high concentrations of codeine, dihydrocodeine, morphine, methadone and morphine-3-glucuronide. The investigators highlighted oral morphine maintenance as a locally relevant source.
  325. Pervasive Gabapentin Interference in the LC-MS/MS Analysis of Amphetamine 2018 A laboratory observed distorted amphetamine results in urine samples rich in gabapentin. Updated extraction and chromatography resolved column overload during LC–MS/MS.
  326. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays Drug Test Anal, 2017 Four benzodiazepine tests detected designer benzodiazepines in fortified and authentic urines. These are benzodiazepine-class exposures; a conventional confirmation panel can omit them.
  327. Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens Arch Pathol Lab Med, 1997 After 10 mg zolpidem, healthy volunteers had no positive result on either of two standard urine panels, including their benzodiazepine assays. Temazepam gave positive benzodiazepine results in some specimens.
  328. Consumption of the Sugar Substitute Stevia Leads to Cross-Reactivity of CEDIA® Buprenorphine II Immunoassay J Anal Toxicol, 2021 A rehabilitation-center investigation identified steviol glucuronide, a metabolite of stevia sweetener, as a CEDIA Buprenorphine II interferent above 15,000 micrograms/L in urine.
  329. [Immunochromatographic analysis of determination of narcotic substances using test systems containing gold nanoparticles, on the example of morphine and amphetamine] Sud Med Ekspert, 2020 The prototype amphetamine strip did not give a positive result with epinephrine. Its morphine strip did not give a positive result with codeine. The methods evaluated urine specimens.
  330. Stereoselectivity of the TDxADx/FLx Amphetamine/Methamphetamine II amphetamine/methamphetamine immunoassay--response of urine specimens following nasal inhaler use J Toxicol Clin Toxicol, 1995 An Abbott amphetamine/methamphetamine assay yielded positive results in two specimens from one participant using twice the recommended inhaler dose. Recommended use yielded no positives in this study.
  331. Response of EMIT amphetamine immunoassays to urinary desoxyephedrine following Vicks inhaler use Ther Drug Monit, 1995 In six people using the studied nasal inhaler, some urine samples reacted on the EMIT class assay. Every specimen was negative on the EMIT monoclonal assay.
  332. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I. Stereoselectivity and clinical evaluation Forensic Sci Int, 1993 A monoclonal amphetamine/methamphetamine assay favored the S isomers. In a clinical comparison, the investigators suspected chlorpromazine metabolites in two false-positive results.
  333. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) Forensic Sci Int, 1993 Monoclonal EMIT recognized racemic MDA and MDMA at different thresholds and preferentially recognized their S enantiomers. The dosing experiment was conducted in rats.
  334. Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay J Anal Toxicol, 1991 Among 63 samples from 23 patients taking ranitidine, 12 screened positive on monoclonal EMIT. The first or second urine after dosing accounted for all of those results.
  335. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers J Anal Toxicol, 1993 None of 150 urine specimens from seven inhaler users triggered the EMIT II amphetamine/methamphetamine test at its 1,000 ng/mL cutoff, even though some contained measurable l-methamphetamine.
  336. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing J Anal Toxicol, 1998 Seven men received oral d-amphetamine. The three urine immunoassays agreed with each other, but at the 1,000 ng/mL cutoff only 8 of 42 specimens collected after a 5 mg dose screened positive.
  337. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine J Anal Toxicol, 2004 The Triage propoxyphene test showed cross-reactivity to diphenhydramine and certain tricyclics in urine. The final abstract does not identify the individual tricyclics.
  338. Evaluation of a colloidal metal immunoassay device for the detection of tricyclic antidepressants in urine J Toxicol Clin Toxicol, 1997 A Triage Plus urine TCA test recognized expected tricyclics, including clomipramine and protriptyline. Cyclobenzaprine gave a cross-reaction at 1,000 ng/mL in fortified urine.
  339. False-Positive Amphetamines in Urine Drug Screens: A 6-Year Review J Anal Toxicol, 2023 A six-year investigation of positive CEDIA amphetamine/ecstasy screens in routine and referred specimens combined broad mass-spectrometry testing with laboratory challenges to investigate discordant results.
  340. Pirfenidone causes false-positive urine benzodiazepine results: Implications for patients with pulmonary fibrosis J Heart Lung Transplant, 2018 This paper reports false-positive urine benzodiazepine results with pirfenidone in the setting of pulmonary fibrosis.
  341. Up in Smoke: Uncovering a Lack of Evidence for Proton Pump Inhibitors as a Source of Tetrahydrocannabinol Immunoassay False Positives Pain Med, 2018 An EMIT II Plus cannabinoid study found no positive result in spiked urine or in samples from 32 people taking proton pump inhibitors. None of 50 low-positive or false-positive specimens contained a proton pump inhibitor.
  342. Premier Biotech OralTox oral-fluid drug test. FDA 510(k) summary K181305 2018 Benzocaine at 10 µg/mL did not interfere on the eight oral-fluid channels studied, including cocaine. The manufacturer evaluated three lots.
  343. False-positive benzodiazepine urine test due to oxaprozin JAMA, 1995 This earlier report identified oxaprozin as a cause of a positive urine benzodiazepine screen.
  344. Fenofibric Acid Can Cause False-Positive Urine Methylenedioxymethamphetamine Immunoassay Results J Anal Toxicol, 2015 A fenofibrate-treated patient’s DRI MDMA screen turned negative after treatment stopped. Spiking experiments estimated that 225 micrograms/mL of fenofibric acid could give a positive result.
  345. Solriamfetol and m-chlorophenylpiperazine cause false positive amphetamine results on urine drug screening J Anal Toxicol, 2024 A Thermo DRI amphetamine immunoassay challenge identified solriamfetol and m-CPP, a trazodone metabolite, as interferents among the psychiatric drugs and metabolites tested.
  346. Diagnostic pitfalls and laboratory test interference after hydroxychloroquine intoxication: A case report Toxicol Rep, 2019 After a major hydroxychloroquine overdose, the oxycodone assay issued an absorbance alarm in the more concentrated of two urines. Spiking also produced bias or alarms on several urine tests, including buprenorphine.
  347. Stereoselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis Electrophoresis, 1999 Chiral confirmation identified R-amphetamine and R-methamphetamine in urine from a person taking selegiline. These are genuine drug metabolites.
  348. Randox Laboratories. Evidence MultiSTAT DOA Urine Array EV4193. Tricyclic antidepressant specificity table The manufacturer lists a urine TCA response at approximately 230 ng/mL of cyproheptadine, corresponding to about 65% cross-reactivity against the 150-ng/mL nortriptyline standard.
  349. Randox Toxicology. ELISA Solutions, tricyclic antidepressant assay specificity and specimen protocols 2016 The TCA ELISA specificity table gives under 0.1% relative response for hydroxyzine and 0.3% for cetirizine. Nortriptyline is the reference compound. The brochure also describes blood and urine protocols.
  350. Determination of designer drug cross-reactivity on five commercial immunoassay screening kits J Anal Toxicol, 2015 Table I mapped all 94 separately fortified compounds across five assays in certified drug-free urine. The results include related-drug recognition, drug-specific assay differences and negative challenges at 100 µg/mL. These laboratory concentrations do not establish rates in patients.
  351. Effect of intranasal cocaine on the urine drug screen for benzoylecgonine Otolaryngol Head Neck Surg, 1992 Medicinal cocaine used during nasal procedures or sprayed in volunteers produced urinary benzoylecgonine. Every participant tested positive at 24 hours after intranasal application.
  352. Positive interference of the analgesic nefopam in the urine immunoassay for benzodiazepines in a secure setting J Psychopharmacol, 2009 A psychiatric inpatient receiving nefopam had repeated positive urine benzodiazepine screens. Urine screens became negative after nefopam was withdrawn.
  353. The incidence of Zolpidem use in suspected DUI drivers in Miami-Dade Florida: a comparative study using immunalysis Zolpidem ELISA KIT and gas chromatography-mass spectrometry screening J Anal Toxicol, 2008 Immunalysis zolpidem ELISA did not react to zaleplon or zopiclone spiked into urine at 1,000 ng/mL. Authentic specimens confirmed the intended drug, zolpidem.
  354. Zolpidem urine excretion profiles and cross-reactivity with ELISA(®) kits in subjects using Zolpidem or Ambien(®) CR as a prescription sleep aid J Anal Toxicol, 2011 In patients taking prescribed zolpidem, two urine ELISAs usually screened positive, including some specimens in which GC-MS found no parent zolpidem. Measured urine concentrations varied across patients.
  355. Crossreactivity of bupropion metabolite with enzyme-linked immunosorbent assays designed to detect amphetamine in urine Ther Drug Monit, 2011 Bupropion metabolites triggered two of four amphetamine or methamphetamine ELISA kits in laboratory testing. Three Amphetamine ULTRA-positive samples contained bupropion-related compounds and lacked GC-MS-confirmed amphetamines.
  356. Failure of amoxicillin to produce false-positive urine screens for cocaine metabolite J Anal Toxicol, 2008 Among 33 amoxicillin users screened on four cocaine tests, both positive specimens contained benzoylecgonine on GC-MS. The investigators found no amoxicillin-related false positives.
  357. How often do false-positive phencyclidine urine screens occur with use of common medications? Clin Toxicol (Phila), 2013 A chart review found tramadol and dextromethorphan more often among unconfirmed PCP screens. The diphenhydramine difference was not statistically significant. Alprazolam, clonazepam and carvedilol were associated with both unconfirmed results and polysubstance use.
  358. A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing Acad Pathol, 2018 An inventory of package inserts found that manufacturers tested different compounds and often omitted known interferents. This supports asking the laboratory for the actual assay and reagent instructions.
  359. Interference with testing for lysergic acid diethylamide Clin Chem, 1997 Some psychiatric patients’ EMIT-positive LSD specimens were negative on alternative methods. Adding medications prescribed to those patients to drug-free urine reproduced positives on the EMIT LSD assay.
  360. Bupropion Overdose Presenting as Status Epilepticus in an Infant Pediatr Neurol, 2015 An infant with severe bupropion poisoning had an initial presumptive amphetamine result. Reagent and confirmatory procedure are not specified in the abstract.
  361. Immunoassay screening of diphenhydramine (Benadryl®) in urine and blood using a newly developed assay J Anal Toxicol, 2012 The experimental diphenhydramine-targeted ELISA showed strong orphenadrine response but little response to several other antihistamines. Its direction is the reverse of diphenhydramine causing a TCA screen.
  362. Comparison of radioimmunoassay with thin-layer chromatographic and gas-liquid chromatographic methods of barbiturate detection in human urine Clin Chem, 1975 The authors reported glutethimide caused false positives on a barbiturate radioimmunoassay in their comparison of urine methods.
  363. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity Pediatr Emerg Care, 2010 A child with suspected diphenhydramine ingestion had a methadone screen that failed GC-MS confirmation. Diphenhydramine reproduced the reaction on the ACON device, while two tested metabolites did not.
  364. Investigation of interference by nonsteroidal anti-inflammatory drugs in urine tests for abused drugs Clin Chem, 1990 Among 510 urines collected during NSAID use, ibuprofen and naproxen each accounted for one unconfirmed cannabinoid screen and one unconfirmed barbiturate screen. No specimen falsely screened positive for benzodiazepines.
  365. Confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC-MS-MS analysis in urine J Anal Toxicol, 2023 An isomer-selective urine UPLC-MS/MS method distinguished delta-8 and delta-9 carboxy metabolites. The finding bears on the specificity of cannabinoid confirmation, separate from screening-antibody responses.
  366. Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine Clin Chem, 2006 This report investigated the interaction between efavirenz glucuronide and six commercial urine THC screens.
  367. Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine Molecules, 2021 The full study compares Emit II Plus with ARK HS Benzodiazepine II and tested both authentic urines and individually fortified designer drugs, demonstrating important differences in within-class detection.
  368. Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine J Anal Toxicol, 1988 In drug-free urine spiked with MDA, MDMA and MDE, all three historical amphetamine assays recognized these amphetamine analogues to different degrees.
  369. Detection of the synthetic drug 4-fluoroamphetamine (4-FA) in serum and urine Forensic Sci Int, 2012 Two driver urines screened positive on CEDIA DAU amphetamines and 4-fluoroamphetamine was identified without another drug. The authors also measured approximately 6% assay cross-reactivity.
  370. False-positive LSD testing in urine samples from intensive care patients J Anal Toxicol, 1998 Twelve intensive-care patients had unconfirmed CEDIA LSD screens. Their urine contained ambroxol, and further testing reproduced an ambroxol reaction on that assay.
  371. Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic antidepressants Pediatrics, 2007 A study of 52 children and adolescents found no significant TCA reaction to carbamazepine or oxcarbazepine on its urine assay. Carbamazepine did interfere on a serum assay.
  372. Challenges in the interpretation of amphetamine results: differences of reactivity between immunoassay and immunochromatography Scand J Clin Lab Invest, 2026 Among 55 selected emergency urine specimens, enzyme immunoassay false positives were linked to several drugs including tetracaine and procainamide. The strip gave discordant positives with phentermine and bisoprolol. Neither method showed methylphenidate cross-reactivity in this set.
  373. False-positive interferences of common urine drug screen immunoassays: a review J Anal Toxicol, 2014 This review tabulated published reports of urine assay interference across drug classes and identified historical reports relevant to some of the checker’s LSD records.
  374. False positive urine drug screens J Anal Toxicol, 2026 The review selected 61 reports from 569 PubMed publications and categorized evidence for urine screening interferences reported from 2013 through 2024 by study type.
  375. Interference between ethosuximide and barbiturates in an immunochromatographic method Clin Chem Lab Med, 2018 This paper reports interference from ethosuximide in a urine barbiturate immunochromatographic method.
  376. Diagnostic efficiency of different amphetamine screening tests--the search for an optimal cutoff Clin Chem Lab Med, 2004 In urine that screened positive by Abbott AxSYM for amphetamines but was negative for the targets on Bio-Rad REMEDi HPLC, fluoxetine was one of 11 other substances detected. The authors singled it out as previously known to cross-react.
  377. Presumptive false-positive amphetamine urine screen in a pregnant woman receiving α-methyldopa: A case report Indian J Psychiatry, 2026 This indexed case report describes a presumptive positive urine amphetamine screen in a pregnant patient receiving alpha-methyldopa.
  378. Doxylamine: a cause for false-positive gas chromatographic assay for phencyclidine Ther Drug Monit, 1981 In a patient who took doxylamine and flurazepam, the PCP EMIT urine screen was negative. The erroneous positive arose on the subsequent gas chromatographic test and was attributed to doxylamine.
  379. Cotinine determination by immunoassays may be influenced by other nicotine metabolites Arch Toxicol, 1988 The anti-cotinine antibody recognized trans-3′-hydroxycotinine at about 30% relative reactivity. This can overstate cotinine in people already exposed to nicotine.
  380. Avoid unfavorable consequences: dextromethorpan can bring about a false-positive phencyclidine urine drug screen J Emerg Med, 2000 The original letter identifies dextromethorphan and a false-positive urine PCP screen. The citation discloses neither reagent nor confirmation; stronger assay-specific sources support the existing entry.
  381. Identification of Hexahydrocannabiphorol Metabolites in Human Urine Drug Test Anal, 2025 After a single 4 mg oral HHCP dose, urine from one participant contained HHCP metabolites but tested negative on cannabinoid enzyme immunoassays. The study is about HHCP rather than HHC.
  382. Serotonin Syndrome Associated With Vilazodone Overdose in a 22-Month-Old Treated With Dexmedetomidine J Emerg Med, 2021 A child with laboratory-confirmed vilazodone ingestion screened positive on Roche Amphetamines II, followed by negative GC-MS confirmation for amphetamines.
  383. False-positive results for urine amphetamine and opiate immunoassays in a patient intoxicated with perazine Clin Chem, 1996 This case report links perazine intoxication with false-positive urine immunoassays for both amphetamines and opiates.
  384. Interference of diphenhydramine with the EMIT II immunoassay for propoxyphene J Anal Toxicol, 1999 A laboratory letter identifies diphenhydramine interference with the EMIT II propoxyphene immunoassay.
  385. A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine J Anal Toxicol, 2019 First-generation CEDIA buprenorphine generated 21 false positives in maintenance patients. Bup2, with a different formulation and cutoff, had one unexplained borderline positive. The authors specifically discuss the newer assay in high-dose morphine treatment.
  386. SGLT2 Inhibitors and False Positive Toxicology Tests N Engl J Med, 2024 The case linked empagliflozin-associated glucosuria with fermentation and ethanol formation in a stored urine specimen. A fresh sample helped resolve the unexpected finding.
  387. Metabolite patterns in human urine after oral administration of highly purified Δ8-THCV Forensic Toxicol, 2026 Following controlled delta-8 THCV exposure, pooled urine frequently reacted on a delta-9 THC metabolite screen despite a negative definitive result for the delta-9 THC carboxy metabolite.
  388. False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine Clin Chem, 2002 The authors described three unexpected PCP-positive urine results on a Syva RapidTest panel and identified venlafaxine and O-desmethylvenlafaxine as relevant to the interference.
  389. Urine opiate screening: false-positive result with levofloxacin CMAJ, 2010 During levofloxacin therapy, a patient’s SYNCHRON opiates result was positive while urine and serum mass spectrometry were negative. The urine screen was negative a week after levofloxacin was stopped.
  390. Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine J Anal Toxicol, 2008 Among 29 samples from people taking tramadol, seven buprenorphine screens failed LC-MS/MS confirmation. The CEDIA 5 ng/mL cutoff yielded false positives that disappeared at 20 ng/mL.
  391. [The detection of amphetamines in urine samples using immunochromatographic test strips] Sud Med Ekspert, 2012 No amphetamine was detected on the reported urine strips after participants drank three specific energy drinks. This finding applies to those formulations and the tested strip.
  392. Recent ketamine administration can produce a urine toxic screen which is falsely positive for phencyclidine Pediatr Emerg Care, 1998 This early clinical letter associates recent ketamine administration with an unconfirmed urine PCP screen.
  393. Metabolism of selegiline in humans. Identification, excretion, and stereochemistry of urine metabolites Drug Metab Dispos, 1997 After selegiline administration, GC-MS against reference compounds identified R-methamphetamine as a major urinary metabolite and R-amphetamine as another metabolite.
  394. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration J Anal Toxicol, 2022 In 18 adults, pure CBD administration showed no conversion to THC, whereas vaporizing CBD-dominant cannabis containing measured delta-9 THC produced confirmable THC metabolite in some specimens.
  395. False-positive fentanyl screening kit results during treatment with long term injectable risperidone (Risperdal-Consta) Psychiatry Res, 2021 Three people treated with long-acting injectable risperidone had reportedly false fentanyl positives on a commercial rapid kit.
  396. Fentanyl in the labor epidural impacts the results of intrapartum and postpartum maternal and neonatal toxicology tests Am J Obstet Gynecol, 2023 In a prospective cohort of 33 maternal–infant pairs, fentanyl administered during epidural labor analgesia was subsequently detectable in maternal and some neonatal urine.
  397. Siemens Healthcare Diagnostics. Emit Drugs of Abuse Urine Assays Cross-Reactivity List 2008 Fexofenadine was tested at 1,000 µg/mL and remained below both EMIT II Plus cocaine-metabolite cutoffs.
  398. Siemens Healthineers. EMIT d.a.u. Amphetamine Class Assay. Instructions for use, revision 07, sections 8 and 10, tables 5–6 2024 The EMIT d.a.u. Amphetamine Class insert documents its own response to drugs such as diethylpropion and phenmetrazine, providing a comparator to EMIT II Plus.
  399. Siemens Healthineers. EMIT II Plus Amphetamines Assay. Instructions for use, revision 09, tables 23–24 2024 The EMIT II Plus specification tables distinguish compounds that approach an amphetamine cutoff from negative challenges, including parent drugs cited in older case reports.
  400. Siemens Healthineers. Syva EMIT II LSD Assay. Instructions for use, revision 08, sections 8 and 10 2024 The Siemens insert reports which substances produced signals near the EMIT II LSD cutoff, including ergonovine and methysergide, and flags certain medicines when interpreting results.
  401. False-positive barbiturate test in urine owing to phenytoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin Clin Chem, 1988 A laboratory letter implicated phenytoin and a hydroxylated phenytoin metabolite in a false-positive urine barbiturate result.
  402. Screening and confirmation of drugs in urine: interference of hordenine with the immunoassays and thin layer chromatography methods Forensic Sci Int, 1992 Hordenine reacted with urine immunoassays, most clearly the morphine ELISA. The proposed effect of drinking beer was not demonstrated in a drinking study. The oxymorphone and hydromorphone effects concerned TLC.
  403. Quetiapine and false-positive urine drug testing for tricyclic antidepressants Am J Psychiatry, 2000 This report associates quetiapine with a false-positive urine screen for tricyclic antidepressants.
  404. Naloxone Metabolism Associated With Unexpected Noroxymorphone Detected in Urine During Pregnancy O G Open, 2026 Two pregnant patients receiving buprenorphine/naloxone had presumptive opiate positives and isolated noroxymorphone on confirmation, without detectable parent opioids. The authors linked the low metabolite levels to naloxone.
  405. Isomeric amphetamines--a problem for urinalysis? Forensic Sci Int, 1991 A urine challenge identified N-ethylamphetamine and other synthetic isomers as cross-reactants on historical stimulant screens. GC-MS coelution was a separate observation.
  406. Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content Forensic Sci Int, 2014 In a controlled study of raw poppy seeds with measured alkaloid content, GC-MS detected genuine urinary morphine and codeine. A separate CEDIA heroin-marker screen yielded false positives, while the Lin-Zhi 6-AM test did not.
  407. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry J Anal Toxicol, 1995 After controlled doses, TDx and EMIT detected hydromorphone, hydrocodone and oxycodone for some collections. Neither detected oxymorphone at the study cutoff, and other assays missed still more of these opioids.
  408. Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration J Anal Toxicol, 2000 In Table III, several OTC drugs increased the signal from urine already containing 300 ng/mL morphine on particular assays. This is signal enhancement with target present. Table II separately addresses related opioids.
  409. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration J Anal Toxicol, 2014 After controlled use of an inhaler containing levmetamfetamine, isomer-specific GC-MS found l-methamphetamine and occasional traces of l-amphetamine. It found neither d-isomer. Some EMIT II Plus class screens were positive.
  410. False-positive amphetamine results on several drug screening platforms due to mexiletine Clin Biochem, 2018 Two mexiletine-treated patients screened positive for amphetamines on four devices despite negative mass spectrometry. Adding mexiletine to drug-free urine reproduced the false positives on all four.
  411. A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance Clin Chim Acta, 2011 In a chronic opioid therapy population, the Immunalysis fentanyl HEIA detected 37 of 38 LC-MS/MS-positive urine samples in the initial evaluation. Marked signal suppression was reported at urine pH below 4.
  412. Serum and urine concentrations of flunitrazepam and metabolites, after a single oral dose, by immunoassay and GC-MS J Anal Toxicol, 2001 Four volunteers taking flunitrazepam had serial urine samples tested by GC-MS, SBENZ and TDx. Urinary metabolite recognition and sensitivity differed across these methods.
  413. Mexiletine and False Positive Urine Drug Screen for Amphetamine: A Case Review Case Rep Med, 2021 Sohal and colleagues described a 64-year-old patient taking mexiletine for ventricular arrhythmia. Urine screened positive for amphetamines on two occasions, and quantitative urine testing was negative.
  414. Detection times of pregabalin in urine after illicit use: when should a positive specimen be considered a new intake? Ther Drug Monit, 2013 Serial urine samples contained pregabalin after each of two single doses given to one volunteer. The authors also reviewed published urine concentration data.
  415. Naltrexone and Its Noroxymorphone Minor Metabolite - A Case Report J Psychoactive Drugs, 2020 The case describes detection of noroxymorphone during naltrexone therapy, a potential source of the same metabolite formed downstream of oxycodone.
  416. Determining susceptibility of routine clinical biochemistry assays to methylene blue interference Clin Biochem, 2025 Investigators added methylene blue to leftover patient specimens and compared assay responses with controls. Concentrations above 0.08 mg/L biased the Roche cobas c702 urine amphetamines result upward.
  417. ACMT Position Statement: Interpretation of Urine Opiate and Opioid Tests J Med Toxicol, 2022 ACMT explains the difference between morphine-directed opiate tests and opioid-specific tests, and why urine detection cannot establish dose, intent, timing or impairment. It supports the interpretation guidance across opioid entries.
  418. The dextromethorphan defense: dextromethorphan and the opioid screen Acad Emerg Med, 1995 In a blinded crossover study, urine from 20 adults was negative for opioids six hours after either 20 or 40 mg dextromethorphan. Codeine, the positive control, gave the expected positive result.
  419. Does naloxone cause a positive urine opiate screen? Ann Emerg Med, 1994 In a blinded volunteer study, all EMIT urine opiate screens remained negative after 2 or 4 mg of intravenous naloxone at the three postdose sampling points.
  420. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays J Forensic Sci, 2004 About 27,400 military urine samples were screened on DRI and Abuscreen Online at the same cutoff. Pseudoephedrine was detected in all 833 unconfirmed specimens that contained at least one of the three decongestants investigated.
  421. Gatifloxacin interference with opiate urine drug screen Pharmacotherapy, 2006 A patient taking systemic gatifloxacin had two positive opiate screens, with negative results by the follow-up method. Screening was negative again after the antibiotic course.
  422. Opiate-positive immunoassay screen in a pediatric patient Clin Chem, 2010 A child given naloxone had 9,900 ng/mL of total naloxone in an opiates-positive urine specimen. Adding naloxone to drug-free urine reproduced positivity on the laboratory’s CEDIA assay at 6,100 ng/mL.
  423. Sustiva yields false positives on marijuana tests Crit Path AIDS Proj, 1998 The supplementary PubMed abstract of the 1998 Critical Path AIDS Project notice reports the manufacturer's early warning about efavirenz and urine cannabinoids. It gives no specific assay, patient count or experimental data.
  424. Pholcodine interference in the immunoassay for opiates in urine Forensic Sci Int, 1983 After an oral therapeutic dose of pholcodine, an older opiate radioimmunoassay remained positive considerably longer than the EMIT method. The study included codeine and ethylmorphine for comparison.
  425. Unexpected increase in false-positive results following benzodiazepine immunoassay reformulation Clin Biochem, 2026 After a laboratory switched from Roche BENZ Plus to BNZ2, it identified more confirmed lorazepam exposures but also more unconfirmed benzodiazepine screens.
  426. False positive urine drug screens from quinine in tonic water Addict Behav, 1989 The amount of tonic water used in a mixed drink could produce detectable quinine in urine, undermining the use of quinine as an indirect marker of illicit drug exposure.
  427. Doxylamine toxicity: seizure, rhabdomyolysis and false positive urine drug screen for methadone BMJ Case Rep, 2009 An overdose case with seizures and delayed rhabdomyolysis included an unexpected methadone urine screen after doxylamine ingestion.
  428. Efficacy of DRIVEN-FLOW® M7-II, a new on-site drug screening kit in postmortem urine compared with Triage DOA® Leg Med (Tokyo), 2021 Three named medications occurred among unconfirmed TCA positives on two devices in postmortem urine. The authors pool these observations across cases and devices in the abstract. Presence is not proof of individual causation.
  429. Assessment of Triage DOA®, Status DS10, and DRIVEN-FLOW® M8-Z on-site drug screening kits for postmortem urine Leg Med (Tokyo), 2022 In postmortem urine, quetiapine, chlorpromazine or carbamazepine were present among TCA screen results unconfirmed by mass spectrometry. Individual causality and precise reagent attribution cannot be inferred for all three drugs.
  430. Can tapentadol cause a false-positive urine drug screen result for amphetamine? Clin Toxicol (Phila), 2012 Tang and colleagues prospectively tested urine from 11 patients who reported recent use of immediate-release tapentadol at 50–600 mg/day. None screened positive for amphetamines on the Siemens Syva EMIT II.
  431. False positive opiate immunoassay caused by diphenhydramine Clin Toxicol (Phila), 2022 The authors report a diphenhydramine-associated false opiate immunoassay result. This is a distinct citation from diphenhydramine reports involving PCP, methadone or TCAs.
  432. False-positive buprenorphine EIA urine toxicology results due to high dose morphine: a case report J Addict Dis, 2012 A patient on high-dose morphine repeatedly had buprenorphine-positive immunoassays without GC-MS confirmation. The signal disappeared off morphine and returned when it was restarted.
  433. Thermo Fisher Scientific. CEDIA LSD Assay instructions for use, specificity tables, 10000912-10-EN 2019 The CEDIA insert gives test-specific measurements for compounds including ergonovine and methysergide. These provide comparators for positive findings on other LSD assays.
  434. Thermo Scientific CEDIA Cocaine 150 ng/mL Assay. Cross Reactivity Guide, revision 14 2013 The manufacturer lists both benzocaine and hydroxyzine dihydrochloride in its negative-compound data at 500,000 ng/mL on the CEDIA cocaine assay.
  435. Thermo Scientific DRI Benzodiazepine Assay. Instructions for use, 10025445-0-EN 2018 The low oxazepam control stayed negative and the high control stayed positive with 100,000 ng/mL hydroxyzine on this benzodiazepine assay.
  436. Thermo Scientific. DRI Phencyclidine Assay instructions for use, 0141 2025 Brompheniramine remained negative at 50,000 ng/mL on the DRI urine PCP assay (25 ng/mL phencyclidine cutoff).
  437. Psilocin identified in a DUID investigation J Anal Toxicol, 2006 Investigators confirmed psilocin in urine that screened positive on a combined amphetamine/methamphetamine FPIA. They also measured cross-reactivity to psilocin in laboratory testing.
  438. Validation of the Neogen® Fentanyl ELISA Kit for Blood and Urine J Anal Toxicol, 2017 The final validation established 1 and 5 ng/mL urine decision points for Neogen fentanyl ELISA and lists six analogues or metabolites evaluated. The same authors’ earlier report documents urine-specific acetylfentanyl and norfentanyl responses.
  439. Validation of the Neogen® enzyme-linked immunosorbent assay gabapentin kit for blood and urine J Anal Toxicol, 2026 Validation of the Neogen gabapentin ELISA found false positives in urine containing at least 50 µg/mL levamisole. The assay reliably detected gabapentin at its validated decision point.
  440. Excretion and detection of cathinone, cathine, and phenylpropanolamine in urine after kath chewing Clin Chem, 2002 After four volunteers chewed khat, urine screened positive on the Mahsan amphetamine test but remained negative on an Abbott FPIA. GC-MS identified cathinone, cathine and norephedrine.
  441. Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations J Mass Spectrom Adv Clin Lab, 2024 Roche BNZ2 detected lorazepam and clonazepam metabolites more often than the older BENZ assay. There were still missed LC-MS/MS-positive specimens. This is a within-class detection issue.
  442. [Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine] Chudoku Kenkyu, 2014 In spiked urine, Instant-View M-1 recognized triazolam and some hydroxylated metabolites. Several metabolites and etizolam were missed, illustrating limits on within-class detection.
  443. Response to a report on false-positive results in a methadone enzyme immunoassay Clin Chem, 1998 The manufacturer reported replacing the methadone assay antibody in June 1997 to correct the earlier interference attributed to verapamil metabolites.
  444. Cross-reactivity of the epimers of 11-nor-9-carboxy-hexahydrocannabinol, metabolites of hexahydrocannabinol, with panel tests for urinary Δ9-tetrahydrocannabinol metabolites Forensic Toxicol, 2025 Two HHC carboxy metabolite isomers reacted with three urinary THC panel tests. A specimen from one reported HHC user also reacted on all three.
  445. Cannabinoid mimics in chocolate utilized as an argument in court Int J Legal Med, 2000 Three chocolate-associated ethanolamides tested in urine failed to trigger a cannabinoid screen. The experiment addressed proposed mimics and did not involve feeding participants chocolate.
  446. Vortioxetine use may cause false positive immunoassay results for urine methadone Clin Chim Acta, 2019 Seven people taking usual vortioxetine doses screened positive on Roche KIMS Methadone II, but GC-MS and two comparison immunoassays were negative. The authors implicated a metabolite.
  447. Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl J Appl Lab Med, 2024 Among low-positive Lin-Zhi results, two patients with dextromethorphan exposure had no detectable fentanyl or norfentanyl on LC-MS/MS. The investigators considered dextromethorphan a likely explanation.
  448. Performance of a Xylazine Test Strip in Urine Biospecimens J Addict Med, 2025 In 85 urine specimens tested with the BTNX xylazine strip, three qualitative mass-spectrometry-negative specimens screened positive. The authors identified lidocaine as a likely interferent.
  449. US Food and Drug Administration. Drugs of Abuse Home Use Test Explains the two stages of a home urine drug test and why a person should obtain the laboratory result before acting on a positive home screen.
  450. Validation of a new homogeneous immunoassay for the detection of carisoprodol in urine 2011 The investigators evaluated a carisoprodol urine immunoassay against LC–MS/MS and examined the response to meprobamate, its active metabolite.
  451. Metabolic production of amphetamine following administration of clobenzorex J Forensic Sci, 1999 The investigators measured d-amphetamine in urine by GC-MS after five volunteers each received one 30 mg dose of clobenzorex.
  452. Detection of morphine in urine by hemagglutination inhibition, with use of lyophilized reagents Clin Chem, 1983 Table 1 compares three historical morphine hemagglutination antisera with the Roche RIA. Several related opiates showed strong binding, whereas other drugs produced very weak or unquantifiable responses under these conditions.
  453. Bupropion interference with immunoassays for amphetamines and LSD Ther Drug Monit, 2007 One patient with seizures screened positive for both amphetamines and LSD on CEDIA. Follow-up toxicology identified bupropion and failed to confirm either screen.
  454. False-Positive EtG Immunoassay Screening After Exposure to Aliphatic Alcohols. LC-HRAM-Orbitrap-MS Detection of C1-C6 EtG Homologs in Urine, Chest, and Pubic Hair Samples Drug Test Anal, 2026 An occupational solvent-exposure case had repeated positive urine EtG immunoassays. High-resolution mass spectrometry detected glucuronides of several other alcohols while finding no EtG in the same urine.
  455. An assessment of urine THC immunoassay in healthy volunteers receiving an oral proton-pump inhibitor Clin Toxicol (Phila), 2020 All 12 volunteers tested negative on the THC One Step strip after five days of oral pantoprazole, esomeprazole, lansoprazole or omeprazole.
  456. Dimethylamylamine: a drug causing positive immunoassay results for amphetamines J Anal Toxicol, 2011 DMAA was found by LC-MS/MS in 92.3% of 134 selected military urine samples with amphetamine screens that had failed confirmation. The specimens had been reactive on two kits.
  457. Evaluating Updated Fentanyl Immunoassays for Loperamide Interference J Appl Lab Med, 2025 Six urine fentanyl assays were assessed with loperamide and metabolites. Immunalysis SEFRIA and Thermo DRI reacted to the didesmethyl metabolite, while Abbott iCassette, ARK II and Lin-Zhi II did not react to the tested compounds.
  458. False-positive Fentanyl Urine Detection after Initiation of Labetalol Treatment for Hypertension in Pregnancy: A Case Report J Addict Med, 2022 Three pregnant or postpartum patients being treated with labetalol had presumptive fentanyl-positive urine screens. The report flags this issue in perinatal care.
  459. Understand the FDA-cleared fentanyl testing: A clinical evaluation of the SEFRIA fentanyl immunoassay Drug Alcohol Depend, 2024 The SEFRIA fentanyl evaluation used LC-MS/MS, untargeted testing and spiking to identify haloperidol, labetalol and trazodone as interferents. Together they accounted for 56% of false positives after the laboratory increased its cutoff.
  460. Development of a homogeneous immunoassay for the detection of fentanyl in urine Forensic Sci Int, 2011 A historical fentanyl urine HEIA at a 2 ng/mL cutoff was compared with LC-MS/MS for fentanyl or norfentanyl, with reported sensitivity of 99% and specificity of 95%.
  461. Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing J Addict Med, 2025 During validation of a urine xylazine dipstick with a 10 ng/mL cutoff, the investigators measured 3% cross-reactivity with clonidine in the analytical challenge. On the investigational 10 ng/mL urine xylazine dipstick, clonidine produced a positive result at 300 ng/mL (3% relative reactivity). The xylazine metabolite 4-OH-xylazine was recognized at 10 ng/mL. The authors described a broad panel of other standards challenged in drug-free urine at 100 µg/mL or higher.
  462. Improved screen and confirmation test of 7-aminoflunitrazepam in urine specimens for monitoring flunitrazepam (Rohypnol) exposure J Anal Toxicol, 2002 Diazepam showed off-target recognition in a flunitrazepam-metabolite-specific Cozart assay. Diazepam is an expected class member on a general benzodiazepine screen.
  463. Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine J Anal Toxicol, 2007 A recombinant homogeneous buprenorphine immunoassay recognized norbuprenorphine comparably to the parent compound. Codeine, morphine and dihydrocodeine each showed under 1% cross-reactivity.
  464. Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay J Anal Toxicol, 2014 The DRI fentanyl assay reacted with acetylfentanyl, risperidone and 9-hydroxyrisperidone, also called paliperidone. Five of seven unconfirmed clinical screens contained risperidone and its metabolite.
  465. Validation of a New Recombinant Antibody Fragment (rFab)-Based Homogeneous Enzyme Immunoassay for the Highly Specific Detection of 6-Acetylmorphine in Urine J Anal Toxicol, 2015 A recombinant-antibody 6-AM test showed much weaker interference than older heroin-marker methods. At the tested concentrations, codeine, hydrocodone and oxycodone remained below cutoff, and pentazocine produced no interference in its challenge.
  466. 125I radioimmunoassay for the dual detection of amphetamine and methamphetamine J Forensic Sci, 1994 The dual-amphetamine RIA recognized MDMA and MDA and responded much less to levoamphetamine and levomethamphetamine than to the dextro isomers. Unnamed OTC challenges cannot support drug-specific claims.
  467. Development of application protocols of the Emit® II Plus 6-Acetylmorphine Assay on the ADVIA® 1800 and 2400 Chemistry Systems Forensic Sci Int, 2014 Modified Emit II Plus 6-AM assays on both ADVIA instruments showed minimal response to morphine and its two named glucuronides. No drug-specific absolute negative challenge concentration is reported in the abstract.
  468. A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone J Am Pharm Assoc (2003), 2022 A psychiatric inpatient taking ziprasidone had an unexpected fentanyl-positive urine screen; her history led the clinicians to suspect medication interference.
  469. Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines Clin Chim Acta, 1998 In clinical urines, CEDIA detected lorazepam more sensitively than EMIT II. Dual-negative samples were not confirmed, and the discrepant-positive counts do not identify an off-target medicine.
  470. Wegner KE, Tiscione NB. Validation of the Neogen Enzyme-Linked Immuno-Sorbent Assay (ELISA) Fentanyl Ready-to-Use (RTU) Kit for Whole Blood and Urine Specimens. AAFS abstract K14 American Academy of Forensic Sciences Annual Scientific Meeting, abstract K14, 2015 The same authors as the later Neogen validation report distinguish their directly measured urine responses to acetylfentanyl and norfentanyl from responses in blood.
  471. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine J Anal Toxicol, 1998 In a multicenter urine evaluation, investigators attributed some reduced specificity on the FRONTLINE rapid cocaine test to metabolites of methadone and clozapine.
  472. Quetiapine cross reactivity with urine methadone immunoassays Am J Psychiatry, 2007 Three patients taking quetiapine alone had repeated positive COBAS Integra Methadone II urine results, while LC-MS/MS found no methadone in their plasma.
  473. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples J Anal Toxicol, 2002 In a challenge with 144 compounds, the EMIT II LSD assay cross-reacted with roughly twice as many as CEDIA or DPC RIA. The assays also disagreed in forensic urine specimens.
  474. Tetracaine from urethral ointment causes false positive amphetamine results by immunoassay Clin Toxicol (Phila), 2021 Tetracaine spiking produced a CEDIA Amphetamine/Ecstasy signal above 40 mg/L. A hospital review found tetracaine in 37 of 45 unconfirmed screens, often following urethral ointment used during catheterization.
  475. Detection of 58 fentanyl analogs using ARK fentanyl II and Immunalysis fentanyl immunoassays Clin Biochem, 2023 Analogue-fortified urine demonstrated substantial fentanyl-assay differences, including markedly different recognition of norfentanyl and non-detection of norsufentanil up to 100 ng/mL.
  476. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine Ann Clin Biochem, 1999 The UK NEQAS report identifies six amphetamine-interferent samples with ephedrine, phentermine, labetalol or an ephedrine/phenylpropanolamine mixture. Separate pholcodine-spiked samples led some laboratories to report morphine.
  477. External quality assessment of techniques for the detection of drugs of abuse in urine Ann Clin Biochem, 1994 The UK proficiency scheme found weaker class-screen detection for amobarbital relative to the secobarbital calibrator. This concerns expected detection of a prescribed barbiturate.
  478. Determining the detection of 216 fentanyl analogs and synthetic opioids and predicting epitopes using four commercial immunoassays Clin Biochem, 2025 The 216-opioid challenge found no recognition of alfentanil, remifentanil or norsufentanil on four fentanyl assays within the study’s tested concentration range. The result is assay- and range-specific.
  479. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays J Anal Toxicol, 2023 Six commercial urine cannabinoid immunoassays reacted to several delta-8, delta-10, HHC and hydroxylated CBD derivatives. Parent CBD and 7-carboxy-CBD did not cross-react under the study conditions.
  480. Evaluation of an enzyme immunoassay for the detection of methadone metabolite EDDP [2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine] in urine J Clin Lab Anal, 2014 The authors compared Lin-Zhi EDDP to mass spectrometry in 362 urine specimens. The cross-reactivity section separately compared drug challenges against the 150 and 300 ng/mL screening cutoffs.
  481. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing Clin Chem, 2006 Emit II urine dose-response curves for pseudoephedrine and MDMA showed less response than amphetamine or methamphetamine. Dilution did not rule out coexisting amphetamine.
  482. Cross-reactivity in urine of 53 cannabinoid analogs and metabolites using a carboxylic acid enzyme-linked immunosorbent assay (ELISA) and homogenous enzyme immunoassay (HEIA) kit and immunalysis synthetic cannabinoid HEIA kits J Anal Toxicol, 2025 This study tested 53 cannabinoid analogues and metabolites in fortified urine. Several related compounds reacted on THC screens, while CBD itself went undetected under the tested conditions.
  483. Performance of the Emit® II Plus 6-Acetylmorphine Assay on the Viva-E® analyzer Forensic Sci Int, 2012 The Viva-E Emit II Plus 6-acetylmorphine evaluation describes minimal response to morphine and its two glucuronides. It does not establish a clinically positive result from these substances.
  484. False-positive amphetamine toxicology screen results in three pregnant women using labetalol Obstet Gynecol, 2011 Three pregnant patients treated with escalating labetalol doses for severe hypertension had unexpected urine amphetamine screens. The authors pointed to a structurally similar metabolite.
  485. Diphenhydramine Intoxication With Blood Extended Half-Life and a False Positive Result for Tricyclic Antidepressants Cureus, 2024 An adolescent with analytically documented diphenhydramine intoxication had a positive urine tricyclic antidepressant screen.
  486. Metabolic fate of fenetylline in rat and man Xenobiotica, 1988 After three volunteers received fenetylline, urinary analysis identified amphetamine among the metabolites. Amphetamine was a major human urinary product in the study.
  487. False Positive Tramadol Urine Testing in Patients Taking Fexofenadine: A Tale of Two Consecutive Cases Case Rep Psychiatry, 2023 Two people taking fexofenadine at 180 mg daily had unexpected positive urine tramadol screens.
  488. [Acute poisoning with weight-loss dietary supplement falsely suggesting the use of amphetamine] Przegl Lek, 2013 After ingestion of the multi-ingredient Thermal Pro formulation the Abbott AxSYM amphetamine urine FPIA was positive and LC-MS/MS was negative. DMAA and bitter orange were proposed explanations, without isolation of either agent.